Top List Curated by Listnerd
  • Public list
  • Nov 27th 2012
  • 521 views
  • 618 votes
  • 618 voters
  • 24%

More about Best Drug formulation of All Time:

Best Drug formulation of All Time is a public top list created by Listnerd on Rankly.com on November 27th 2012. Items on the Best Drug formulation of All Time top list are added by the Rankly.com community and ranked using our secret ranking sauce. Best Drug formulation of All Time has gotten 521 views and has gathered 618 votes from 618 voters. Only owner can add items. Just members can vote.

Best Drug formulation of All Time is a top list in the Health & Fitness category on Rankly.com. Are you a fan of Health & Fitness or Best Drug formulation of All Time? Explore more top 100 lists about Health & Fitness on Rankly.com or participate in ranking the stuff already on the all time Best Drug formulation of All Time top list below.

If you're not a member of Rankly.com, you should consider becoming one. Registration is fast, free and easy. At Rankly.com, we aim to give you the best of everything - including stuff like the Best Drug formulation of All Time list.

Get your friends to vote! Spread this URL or share:

Items just added

    1

    Octinoxate and oxybenzone 0.05/0.02 lotion

    • Formulation of: Octinoxate/Oxybenzone
    • Dosage form: Lotion
    • Active ingredient moieties: Octinoxate
    Octinoxate and oxybenzone lotion, for topical administration, consisting of: 0.05mg/mL octinoxate ; 0.02mg/mL oxybenzone.Purpose:Sunscreen
    7.86
    7 votes
    2

    Letrozole 2.5 coated tablet

    • Formulation of: Letrozole
    • Dosage form: Coated tablet
    • Active ingredient moieties: Letrozole
    Letrozole coated tablet, for oral administration, consisting of: 2.5mg/tablet letrozole.Indications:Letrozole Tablets, USP is an aromatase inhibitor indicated for:
    • Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer (1.1)
    • Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy (1.2)
    • First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer (1.3)
    7.43
    7 votes
    3

    White petrolatum 1 jelly

    • Formulation of: Petrolatum
    • Dosage form: Jelly
    • Active ingredient moieties: Petrolatum
    White petrolatum jelly, for topical administration, consisting of: 1kg/kg petrolatum.
    7.29
    7 votes
    4

    Psyllium husk 0.65 granule

    • Formulation of: Psyllium seed husks
    • Dosage form: Granule
    • Active ingredient moieties: Psyllium seed husks
    Psyllium husk granule, for oral administration, consisting of: 0.65mg/mg psyllium husk.Purpose:■ Enhances Liver function, detoxification and anti-inflammatory effects
    ■ Intestinal toxic emissions and health
    ■ Removes constipation and bad breadth
    ■ Dietary Fiber warranty
    ■ Enhances blood pressure and immune system
    ■ Diabetes prevention
    ■ Reduces Cholesterol
    ■ Prevention of adult diseases and osteoporosis
    ■ Removes Gastrointestinal Disorders and stomach gas

    7.67
    6 votes
    5

    Octinoxate and avobenzone 76.8/20.48 lotion

    • Formulation of: Avobenzone/Octinoxate
    • Dosage form: Lotion
    • Active ingredient moieties: Octinoxate
    Octinoxate and avobenzone lotion, for topical administration, consisting of: 20.48mg/mL avobenzone ; 76.8mg/mL octinoxate.Purpose:Sunscreen
    7.50
    6 votes
    6

    Salicylic acid 1 cream

    • Formulation of: Salicylic acid
    • Dosage form: Cream
    • Active ingredient moieties: Octinoxate
    Salicylic acid cream, for topical administration, consisting of: 1mg/g salicylic acid.Purpose:Acne medication
    7.50
    6 votes
    7

    Iron dextran 50 injectable solution

    • Formulation of: Iron
    • Dosage form: Injectable solution
    • Active ingredient moieties: Iron
    Iron dextran injectable solution, for intravenous administration, consisting of: 50mg/mL iron dextran.
    7.17
    6 votes
    8
    9.50
    4 votes
    9

    Verapamil hydrochloride 100 extended release capsule

    • Formulation of: Verapamil
    • Dosage form: Extended release capsule
    • Active ingredient moieties: Verapamil
    Verapamil hydrochloride extended release capsule, for oral administration, consisting of: 100mg/capsule verapamil hydrochloride.Indications:Verapamil hydrochloride is a calcium channel blocker indicated for the management of essential hypertension. (1)
    8.20
    5 votes
    10

    Oxcarbazepine 300 film coated tablet

    • Formulation of: Oxcarbazepine
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Oxcarbazepine
    Oxcarbazepine film coated tablet, for oral administration, consisting of: 300mg/tablet oxcarbazepine.Indications:Trileptal is an antiepileptic drug indicated for:
    • Adults:
      - Monotherapy or adjunctive therapy in the treatment of partial seizures
    • Children:
      - Monotherapy in the treatment of partial seizures in children 4-16 years
      - Adjunctive therapy in the treatment of partial seizures in children 2-16 years (1)
    6.83
    6 votes
    11

    Eszopiclone 2 coated tablet

    • Formulation of: Eszopiclone
    • Dosage form: Coated tablet
    • Active ingredient moieties: Eszopiclone
    Eszopiclone coated tablet, for oral administration, consisting of: 2mg/tablet eszopiclone.
    7.80
    5 votes
    12

    Black birch 0.1 injectable solution

    • Formulation of: Betula lenta pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Betula lenta pollen
    Black birch injectable solution, for intradermal / subcutaneous administration, consisting of: 0.1g/mL betula lenta pollen.
    6.67
    6 votes
    13

    Kali phos , mag phos , nat sulphuricum 6/6/6 tablet

    • Formulation of: Sodium cation/Potassium cation/Magnesium cation
    • Dosage form: Tablet
    • Active ingredient moieties: Potassium
    Kali phos , mag phos , nat sulphuricum tablet, for oral administration, consisting of: 6[hp_X]/tablet magnesium phosphate, tribasic, pentahydrate ; 6[hp_X]/tablet potassium phosphate ; 6[hp_X]/tablet sodium sulfate.
    6.67
    6 votes
    14

    Amoxapine 25 tablet

    • Formulation of: Amoxapine
    • Dosage form: Tablet
    • Active ingredient moieties: Amoxapine
    Amoxapine tablet, for oral administration, consisting of: 25mg/tablet amoxapine.
    7.60
    5 votes
    15

    Antimony potassium tartrate 30 pellet

    • Formulation of: Antimony cation (3+) homeopathic preparation
    • Dosage form: Pellet
    • Active ingredient moieties: Antimony cation (3+)
    Antimony potassium tartrate pellet, for sublingual administration, consisting of: 30[hp_C]/pellet antimony potassium tartrate.
    8.75
    4 votes
    16

    Avobenzone, octinoxate, and octisalate 24/74/30 lotion

    • Formulation of: Avobenzone/Octinoxate/Octisalate
    • Dosage form: Lotion
    • Active ingredient moieties: Avobenzone
    Avobenzone, octinoxate, and octisalate lotion, for topical administration, consisting of: 24mg/mL avobenzone ; 74mg/mL octinoxate ; 30mg/mL octisalate.
    8.75
    4 votes
    17
    5.71
    7 votes
    18

    Frangula californica bark 30 pellet

    • Formulation of: Frangula californica bark homeopathic preparation
    • Dosage form: Pellet
    • Active ingredient moieties: Frangula californica bark
    Frangula californica bark pellet, for oral administration, consisting of: 30[hp_C]/mL frangula californica bark.Purpose:Purpose: HEADACHE
    10.00
    3 votes
    19

    Metronidazole 7.5 lotion

    • Formulation of: Metronidazole
    • Dosage form: Lotion
    • Active ingredient moieties: Metronidazole
    Metronidazole lotion, for topical administration, consisting of: 7.5mg/g metronidazole.
    7.40
    5 votes
    20

    .alpha.-tocopherol, .beta.-carotene, ascorbic acid, calcium carbonate, cholecalciferol, cupric oxide, cyanocobalamin, doconexent, folic acid, iron, magnesium oxide, niacinamide, omega-3-acid ethyl esters, pyridoxine hydrochloride, riboflavin, thiamine mon

    • Formulation of: .beta.-carotene/Ascorbic acid/Cholecalciferol/.alpha.-tocopherol/Thiamine/Riboflavin/Niacinamide/Pyridoxine/Folic acid/Cyanocobalamin/Calcium/Iron/Magnesium/Zinc/Cupric cation/Omega-3-acid ethyl esters/Doconexent
    • Dosage form: Drug Kit
    • Active ingredient moieties: Beta-carotene
    .alpha.-tocopherol, .beta.-carotene, ascorbic acid, calcium carbonate, cholecalciferol, cupric oxide, cyanocobalamin, doconexent, folic acid, iron, magnesium oxide, niacinamide, omega-3-acid ethyl esters, pyridoxine hydrochloride, riboflavin, thiamine mononitrate, and zinc oxide kit, for oral administration, consisting of: 3mg .alpha.-tocopherol ; 3000[iU] .beta.-carotene ; 120mg ascorbic acid ; 200mg calcium carbonate ; 400[iU] cholecalciferol ; 2mg cupric oxide ; 12ug cyanocobalamin ; 295mg doconexent ; 1mg folic acid ; 29mg iron ; 25mg magnesium oxide ; 20mg niacinamide ; 430mg omega-3-acid ethyl esters ; 25mg pyridoxine hydrochloride ; 4mg riboflavin ; 1.8mg thiamine mononitrate ; 25mg zinc oxide.
    8.50
    4 votes
    21
    8.50
    4 votes
    22

    Levofloxacin 750 film coated tablet

    • Formulation of: Levofloxacin
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Levofloxacin
    Levofloxacin film coated tablet, for oral administration, consisting of: 750mg/tablet levofloxacin.Indications:LEVAQUIN® is a fluoroquinolone antibacterial indicated in adults (≥18 years of age) with infections caused by designated, susceptible bacteria (1 , 12.4).
    • Pneumonia: nosocomial (1.1) and community acquired (1.2, 1.3)
    • Acute bacterial sinusitis (1.4)
    • Acute bacterial exacerbation of chronic bronchitis (1.5)
    • Skin and skin structure infections: complicated (1.6) and uncomplicated (1.7)
    • Chronic bacterial prostatitis (1.8)
    • Urinary tract infections: complicated (1.9, 1.10) and uncomplicated (1.12)
    • Acute pyelonephritis (1.11)
    • Inhalational anthrax, post-exposure (1.13). Not tested in humans for post-exposure prevention of inhalational anthrax; plasma concentrations are likely to predict efficacy (14.9)
    9.67
    3 votes
    23

    Ciprofloxacin hydrochloride 250 tablet

    • Formulation of: Ciprofloxacin
    • Dosage form: Tablet
    • Active ingredient moieties: Ciprofloxacin
    Ciprofloxacin hydrochloride tablet, for oral administration, consisting of: 250mg/tablet ciprofloxacin hydrochloride.
    7.20
    5 votes
    24

    Doxorubicin hydrochloride 2 liposomal injectable

    • Formulation of: Doxorubicin
    • Dosage form: Liposomal injectable
    • Active ingredient moieties: Doxorubicin
    Doxorubicin hydrochloride liposomal injectable, for intravenous administration, consisting of: 2mg/mL doxorubicin hydrochloride.Indications:DOXIL is an anthracycline topoisomerase inhibitor indicated for:
    • Ovarian cancer (1.1)
      After failure of platinum-based chemotherapy.
    • AIDS-related Kaposi's Sarcoma (1.2)
      After failure of prior combination chemotherapy or intolerance to such therapy. Results are based on objective response rate; no results are available from controlled trials that demonstrate clinical benefit.
    • Multiple Myeloma (1.3)
      In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy.
    7.20
    5 votes
    25

    Alcohol 249.3 liquid

    • Formulation of: Rosin/Potassium cation/Alcohol
    • Dosage form: Liquid
    • Active ingredient moieties: Rosin
    Alcohol liquid, for topical administration, consisting of: 249.3mg/mL alcohol ; 59.61mg/mL potassium hydroxide ; 24.7mg/mL rosin.Purpose:Usage: Intended for cleaning and mild antisepsis of skin.
    7.00
    5 votes
    26
    7.00
    5 votes
    27

    Gentamicin sulfate 1 injectable solution

    • Formulation of: Gentamicin
    • Dosage form: Injectable solution
    • Active ingredient moieties: Gentamicin
    Gentamicin sulfate injectable solution, for intravenous administration, consisting of: 1mg/mL gentamicin sulfate.
    7.00
    5 votes
    28

    Aspergillus repens 20000 injectable solution

    • Formulation of: Eurotium herbariorum extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Eurotium herbariorum
    Aspergillus repens injectable solution, for subcutaneous / intradermal administration, consisting of: 20000[PNU]/mL eurotium herbariorum.
    8.00
    4 votes
    29

    Chelidonium majus, phytolacca decandra, arnica montana, nitricum acidum, nux vomica, phosphoricum acidum, aspartic acid, diketopiperazine, dopamine, formalinum, 30/6/30/3/30/30/30/30/30/12/30/12/3/12 liquid

    • Formulation of: Chelidonium majus/Phytolacca americana root/Arnica montana/Nitric acid/Strychnos nux-vomica seed/Phosphoric acid/Aspartic acid/Dopamine/Formaldehyde/Formic acid/Methyl alcohol/Monosodium glutamate/Phenylalanine/2,5-piperazinedione homeopathic preparation
    • Dosage form: Liquid
    • Active ingredient moieties: Greater celandine
    Chelidonium majus, phytolacca decandra, arnica montana, nitricum acidum, nux vomica, phosphoricum acidum, aspartic acid, diketopiperazine, dopamine, formalinum, liquid, for oral administration, consisting of: 30[hp_X]/mL 2,5-piperazinedione ; 6[hp_X]/mL arnica montana ; 30[hp_X]/mL aspartic acid ; 3[hp_X]/mL chelidonium majus ; 30[hp_X]/mL dopamine ; 30[hp_X]/mL formaldehyde ; 30[hp_X]/mL formic acid ; 30[hp_X]/mL methyl alcohol ; 30[hp_X]/mL monosodium glutamate ; 12[hp_X]/mL nitric acid ; 30[hp_X]/mL phenylalanine ; 12[hp_X]/mL phosphoric acid ; 3[hp_X]/mL phytolacca americana root ; 12[hp_X]/mL strychnos nux-vomica seed.Purpose: INDICATIONS: For temporary relief of symptoms related to Aspartame toxicity including headache, dizziness, mood changes, vomiting and nausea, abdominal cramps and pain, vision change, fatigue and weakness and memory loss.
    9.00
    3 votes
    30

    Nitroglycerin 400 metered spray

    • Formulation of: Nitroglycerin
    • Dosage form: Metered Spray
    • Active ingredient moieties: Nitroglycerin
    Nitroglycerin metered spray, for oral administration, consisting of: 400ug nitroglycerin.
    9.00
    3 votes
    31
    6.60
    5 votes
    32
    6.60
    5 votes
    33

    Benzoyl peroxide 0.025 lotion

    • Formulation of: Benzoyl peroxide
    • Dosage form: Lotion
    • Active ingredient moieties: Benzoic acid
    Benzoyl peroxide lotion, for topical administration, consisting of: 0.025mL/mL benzoyl peroxide.
    7.50
    4 votes
    34

    Memantine hydrochloride 7 extended release capsule

    • Formulation of: Memantine
    • Dosage form: Extended release capsule
    • Active ingredient moieties: Memantine
    Memantine hydrochloride extended release capsule, for oral administration, consisting of: 7mg/capsule memantine hydrochloride.Indications:NAMENDA XR contains memantine HCl, an NMDA receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer's type. (1)
    7.50
    4 votes
    35

    Sevelamer hydrochloride 800 tablet

    • Formulation of: Sevelamer
    • Dosage form: Tablet
    • Active ingredient moieties: Sevelamer
    Sevelamer hydrochloride tablet, for oral administration, consisting of: 800mg/tablet sevelamer hydrochloride.Indications:
    • Renagel® is a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis. (1)
    7.50
    4 votes
    36

    Sodium chloride 30 pellet

    • Formulation of: Sodium chloride
    • Dosage form: Pellet
    • Active ingredient moieties: Sodium
    Sodium chloride pellet, for oral administration, consisting of: 30[hp_C]/pellet sodium chloride.Purpose:To relieve the symptoms of sneezing.
    7.50
    4 votes
    37

    Zinc acetate and zinc gluconate 2/2 swab

    • Formulation of: Zinc homeopathic preparation
    • Dosage form: Swab
    • Active ingredient moieties: Zinc
    Zinc acetate and zinc gluconate swab, for nasal administration, consisting of: 2[hp_X]/swab zinc acetate ; 2[hp_X]/swab zinc gluconate.
    7.50
    4 votes
    38

    Amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate 2.5/2.5/2.5/2.5 tablet

    • Formulation of: Dextroamphetamine/Amphetamine
    • Dosage form: Tablet
    • Active ingredient moieties: Dextroamphetamine
    Amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate tablet, for oral administration, consisting of: 2.5mg/tablet amphetamine aspartate ; 2.5mg/tablet amphetamine sulfate ; 2.5mg/tablet dextroamphetamine saccharate ; 2.5mg/tablet dextroamphetamine sulfate.
    8.67
    3 votes
    39
    8.67
    3 votes
    40

    Sodium bicarbonate 75 injectable solution

    • Formulation of: Sodium bicarbonate
    • Dosage form: Injectable solution
    • Active ingredient moieties: Sodium
    Sodium bicarbonate injectable solution, for intravenous administration, consisting of: 75mg/mL sodium bicarbonate.
    6.40
    5 votes
    41

    Chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hydrochloride 1/2.5/2.5 solution

    • Formulation of: Dextromethorphan/Chlorpheniramine/Phenylephrine
    • Dosage form: Solution
    • Active ingredient moieties: Chlorpheniramine
    Chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hydrochloride solution, for oral administration, consisting of: 1mg/mL chlorpheniramine maleate ; 2.5mg/mL dextromethorphan hydrobromide ; 2.5mg/mL phenylephrine hydrochloride.Purpose:Antihistamine
    Cough Suppressant
    Nasal Decongestant
    7.25
    4 votes
    42

    Mycobacterium phlei 1.2 solution/drops

    • Formulation of: Mycobacterium phlei homeopathic preparation
    • Dosage form: Solution/drops
    • Active ingredient moieties: Mycobacterium phlei
    Mycobacterium phlei solution/drops, for oral administration, consisting of: 1.2[HP_X]/mL mycobacterium phlei.
    7.25
    4 votes
    43

    Salicylic acid 0.005 cloth

    • Formulation of: Salicylic acid
    • Dosage form: Cloth
    • Active ingredient moieties: Octinoxate
    Salicylic acid cloth, for topical administration, consisting of: 0.005mg/mg salicylic acid.Purpose:Acne Treatment
    7.25
    4 votes
    44

    Salicylic acid 50 liquid

    • Formulation of: Salicylic acid
    • Dosage form: Liquid
    • Active ingredient moieties: Octinoxate
    Salicylic acid liquid, for topical administration, consisting of: 50mg/mL salicylic acid.
    7.25
    4 votes
    45

    Western ragweed 0.05 injectable solution

    • Formulation of: Ambrosia psilostachya pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Ambrosia psilostachya pollen
    Western ragweed injectable solution, for subcutaneous / intradermal administration, consisting of: 0.05g/mL ambrosia psilostachya pollen.
    7.25
    4 votes
    46

    Zinc acetate anhydrous and zinc gluconate 2/1 multilayer tablet

    • Formulation of: Zinc homeopathic preparation
    • Dosage form: Multilayered Tablet
    • Active ingredient moieties: Zinc
    Zinc acetate anhydrous and zinc gluconate multilayer tablet, for oral administration, consisting of: 2[hp_X]/tablet zinc acetate anhydrous ; 1[hp_X]/tablet zinc gluconate.Purpose:Reduces duration and severity of the common cold
    7.25
    4 votes
    47

    Acetaminophen, dextromethorphan hbr, and diphenhydramine hcl 65/2/2.5 liquid

    • Formulation of: Acetaminophen/Dextromethorphan/Diphenhydramine
    • Dosage form: Liquid
    • Active ingredient moieties: Paracetamol
    Acetaminophen, dextromethorphan hbr, and diphenhydramine hcl liquid, for oral administration, consisting of: 65mg/mL acetaminophen ; 2mg/mL dextromethorphan hydrobromide ; 2.5mg/mL diphenhydramine hydrochloride.Purpose:Pain Relief Cough Suppressant Antihistamine
    8.33
    3 votes
    48

    Alanine, arginine, calcium acetate, cysteine, glycerin, glycine, histidine, isoleucine, leucine, lysine, magnesium acetate, methionine, phenylalanine, phosphoric acid, potassium chloride, potassium metabisulfite, proline, serine, sodium acetate, sodium ch

    • Formulation of: Glycerin/Isoleucine/Leucine/Lysine/Methionine/Phenylalanine/Threonine/Tryptophan/Valine/Alanine/Glycine/Arginine/Histidine/Proline/Serine/Cysteine/Sodium cation/Magnesium cation/Calcium cation/Potassium cation/Phosphoric acid
    • Dosage form: Injectable
    • Active ingredient moieties: Glycerol
    Alanine, arginine, calcium acetate, cysteine, glycerin, glycine, histidine, isoleucine, leucine, lysine, magnesium acetate, methionine, phenylalanine, phosphoric acid, potassium chloride, potassium metabisulfite, proline, serine, sodium acetate, sodium chloride, threonine, tryptophan, and valine injection, for intravenous administration, consisting of: 2.1mg/mL alanine ; 2.9mg/mL arginine ; 0.26mg/mL calcium acetate ; 0.14mg/mL cysteine ; 30mg/mL glycerin ; 4.2mg/mL glycine ; 0.85mg/mL histidine ; 2.1mg/mL isoleucine ; 2.7mg/mL leucine ; 2.2mg/mL lysine ; 0.54mg/mL magnesium acetate ; 1.6mg/mL methionine ; 1.7mg/mL phenylalanine ; 0.41mg/mL phosphoric acid ; 1.5mg/mL potassium chloride ; 0.5mg/mL potassium metabisulfite ; 3.4mg/mL proline ; 1.8mg/mL serine ; 2mg/mL sodium acetate ; 1.2mg/mL sodium chloride ; 1.2mg/mL threonine ; 0.46mg/mL tryptophan ; 2mg/mL valine.
    8.33
    3 votes
    49

    Menthol 0.16 aerosol

    • Formulation of: Menthol
    • Dosage form: Aerosol
    • Active ingredient moieties: Menthol
    Menthol aerosol, for topical administration, consisting of: 0.16g/mL menthol.
    8.33
    3 votes
    50

    Belladonna, sodium borate, hepar sulphuris calcareum, nitricum acidum 30/30/30/30 tablet

    • Formulation of: Atropa belladonna/Sodium cation/Calcium cation/Nitric acid homeopathic preparation
    • Dosage form: Tablet
    • Active ingredient moieties: Deadly nightshade
    Belladonna, sodium borate, hepar sulphuris calcareum, nitricum acidum tablet, for oral administration, consisting of: 30[hp_X]/tablet atropa belladonna ; 30[hp_X]/tablet calcium sulfide ; 30[hp_X]/tablet nitric acid ; 30[hp_X]/tablet sodium borate.Purpose:as an aid in reducing pain and swelling of the mouth and teeth
    9.50
    2 votes
    51

    Hepar sulphuris calcarem, kali iodatum, gelsemium sempervirens, natrum arsenicosum, muriaticum acidum 0.4/0.4/0.4/0.4/0.4 liquid

    • Formulation of: Gelsemium sempervirens root/Sulfate ion/Potassium cation/Sodium cation/Hydrochloric acid homeopathic preparation
    • Dosage form: Liquid
    • Active ingredient moieties: Gelsemium sempervirens root
    Hepar sulphuris calcarem, kali iodatum, gelsemium sempervirens, natrum arsenicosum, muriaticum acidum liquid, for oral administration, consisting of: 0.4[hp_C]/mL calcium sulfide ; 0.4[hp_C]/mL gelsemium sempervirens root ; 0.4[hp_C]/mL hydrochloric acid ; 0.4[hp_C]/mL potassium iodide ; 0.4[hp_C]/mL sodium arsenate, dibasic.Purpose:Homeopathic remedy provides relief from the symptoms of sinus or upper
    respiratory infections, colds and allergies including: runny nose, watery
    eyes, sneezing and congestion.
    9.50
    2 votes
    52
    9.50
    2 votes
    53

    Aloe vera leaf and iodoquinol 10/12.5 gel

    • Formulation of: Aloe vera leaf/Iodoquinol
    • Dosage form: Gel
    • Active ingredient moieties: Aloe vera leaf
    Aloe vera leaf and iodoquinol gel, for topical administration, consisting of: 10mg/g aloe vera leaf ; 12.5mg/g iodoquinol.
    7.00
    4 votes
    54

    Hepatolite 2 lyophilized powder for injectable solution

    • Formulation of: Technetium tc-99m disofenin
    • Dosage form: Lyophilized powder for injectable solution
    • Active ingredient moieties: Technetium tc-99m disofenin
    Hepatolite lyophilized powder for injectable solution, for intravenous administration, consisting of: 2mg/mL disofenin.
    7.00
    4 votes
    55

    Dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride 2/20/1 liquid

    • Formulation of: Guaifenesin/Phenylephrine/Dextromethorphan
    • Dosage form: Liquid
    • Active ingredient moieties: Dextromethorphan
    Dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride liquid, for oral administration, consisting of: 2mg/mL dextromethorphan hydrobromide ; 20mg/mL guaifenesin ; 1mg/mL phenylephrine hydrochloride.Purpose: Uses:
    • temporarily relieves nasal congestion due to the common cold and thin bronchial secretions to make coughs more
    productive • temporary relief of cough due to minor throat and bronchial irritation • helps to control reflex that causes coughing.
    6.00
    5 votes
    56

    Antimonium tartaricum, arsenicum iodatum, asafoetida, baptisia tinctoria, echinacea, eupoatorium perfoliatum, euphorbia pilulifera, hepar sulphuris calcareum, 6/200/30/3/30/3/3/3/30/200/200/30/200/30/3/30 spray

    • Formulation of: Antimony/Arsenic/Asafetida/Baptisia tinctoria root/Echinacea, unspecified/Euphorbia hirta/Calcium/Potassium cation/Lachesis muta venom/Mercuric cation/Rancid beef/Silicon/Teucrium marum/Eupatorium perfoliatum flowering top/Goldenseal/Wood creosote homeopa
    • Dosage form: Spray
    • Active ingredient moieties: Antimony
    Antimonium tartaricum, arsenicum iodatum, asafoetida, baptisia tinctoria, echinacea, eupoatorium perfoliatum, euphorbia pilulifera, hepar sulphuris calcareum, spray, for oral administration, consisting of: 6[hp_X]/mL antimony potassium tartrate ; 200[hp_C]/mL arsenic triiodide ; 30[hp_C]/mL asafetida ; 3[hp_X]/mL baptisia tinctoria root ; 30[hp_X]/mL calcium sulfide ; 3[hp_X]/mL echinacea, unspecified ; 3[hp_X]/mL eupatorium perfoliatum flowering top ; 3[hp_X]/mL euphorbia hirta ; 30[hp_C]/mL goldenseal ; 200[hp_C]/mL lachesis muta venom ; 200[hp_C]/mL mercuric iodide ; 30[hp_C]/mL potassium dichromate ; 200[hp_C]/mL rancid beef ; 30[hp_C]/mL silicon dioxide ; 3[hp_X]/mL teucrium marum ; 30[hp_C]/mL wood creosote.Purpose: USES: Promotes sinus drainage and temporarily relieves these symptoms associated with sinus congestion and sinus related headache: sinus congestion sinus pressure headache pain


    8.00
    3 votes
    57

    Crude calcium sulfide 30 pellet

    • Formulation of: Calcium cation homeopathic preparation
    • Dosage form: Pellet
    • Active ingredient moieties: Calcium
    Crude calcium sulfide pellet, for sublingual administration, consisting of: 30[hp_C]/pellet calcium sulfide.Purpose:SKIN ERUPTIONS,  OR OTHER INDICATIONS
    8.00
    3 votes
    58

    Darifenacin 7.5 extended release tablet

    • Formulation of: Darifenacin
    • Dosage form: Extended release tablet
    • Active ingredient moieties: Darifenacin
    Darifenacin extended release tablet, for oral administration, consisting of: 7.5mg/tablet darifenacin.
    8.00
    3 votes
    59

    Nimodipine 30 gelatin coated capsule

    • Formulation of: Nimodipine
    • Dosage form: Gelatin coated capsule
    • Active ingredient moieties: Nimodipine
    Nimodipine gelatin coated capsule, for oral administration, consisting of: 30mg/capsule nimodipine.
    8.00
    3 votes
    60
    8.00
    3 votes
    61

    Witch hazel 0.00086 liquid

    • Formulation of: Witch-hazel
    • Dosage form: Liquid
    • Active ingredient moieties: Witch-hazel
    Witch hazel liquid, for topical administration, consisting of: 0.00086kg/mL witch hazel.
    8.00
    3 votes
    62
    6.75
    4 votes
    63

    Urtica dioica pollen 50 injectable solution

    • Formulation of: Urtica dioica pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Urtica dioica pollen
    Urtica dioica pollen injectable solution, for percutaneous / subcutaneous administration, consisting of: 50mg/mL urtica dioica pollen.
    6.75
    4 votes
    64

    Chlorpheniramine maleate and codeine phosphate 0.266/1 suspension

    • Formulation of: Codeine/Chlorpheniramine
    • Dosage form: Suspension
    • Active ingredient moieties: Chlorpheniramine
    Chlorpheniramine maleate and codeine phosphate suspension, for oral administration, consisting of: 0.266mg/mL chlorpheniramine maleate ; 1mg/mL codeine phosphate.Purpose:Temporarily relieves: cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants; the intensity of coughing; the impulse to cough to help you go to sleep; temporarily decreases runny nose and reduces sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever or other upper respiratory allergies Warnings
    9.00
    2 votes
    65

    Penicillium chrysogenum var. chrysogenum 4 tablet

    • Formulation of: Penicillium chrysogenum var. chrysogenum homeopathic preparation
    • Dosage form: Tablet
    • Active ingredient moieties: Penicillium chrysogenum var. chrysogenum
    Penicillium chrysogenum var. chrysogenum tablet, for oral administration, consisting of: 4[hp_X]/tablet penicillium chrysogenum var. chrysogenum.Purpose:Viral infections, including herpes
    9.00
    2 votes
    66

    Acer negundo pollen 50 injectable solution

    • Formulation of: Acer negundo pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Acer negundo pollen
    Acer negundo pollen injectable solution, for percutaneous / subcutaneous administration, consisting of: 50mg/mL acer negundo pollen.
    7.67
    3 votes
    67

    Buprenorphine hydrochloride and naloxone hydrochloride 2/0.5 tablet

    • Formulation of: Buprenorphine/Naloxone
    • Dosage form: Tablet
    • Active ingredient moieties: Buprenorphine
    Buprenorphine hydrochloride and naloxone hydrochloride tablet, for sublingual administration, consisting of: 2mg/tablet buprenorphine hydrochloride ; 0.5mg/tablet naloxone hydrochloride.Indications:SUBOXONE sublingual tablet is indicated for the maintenance treatment of opioid dependence. Prescription use of this product is limited under the Drug Addiction Treatment Act. (1)
    7.67
    3 votes
    68

    Gentamicin sulfate 0.8 injectable solution

    • Formulation of: Gentamicin
    • Dosage form: Injectable solution
    • Active ingredient moieties: Gentamicin
    Gentamicin sulfate injectable solution, for intravenous administration, consisting of: 0.8mg/mL gentamicin sulfate.
    7.67
    3 votes
    69

    Tizanidine hydrochloride 6 capsule

    • Formulation of: Tizanidine
    • Dosage form: Capsule
    • Active ingredient moieties: Tizanidine
    Tizanidine hydrochloride capsule, for oral administration, consisting of: 6mg/capsule tizanidine hydrochloride.
    7.67
    3 votes
    70
    10.00
    1 votes
    71

    Dexpanthenol 0.002 liquid

    • Formulation of: Dexpanthenol/Levomenthol/Salicylic acid
    • Dosage form: Liquid
    • Active ingredient moieties: Dexpanthenol
    Dexpanthenol liquid, for topical administration, consisting of: 0.002mL/mL dexpanthenol ; 0.003mL/mL levomenthol ; 0.0025mL/mL salicylic acid.
    10.00
    1 votes
    72

    Psyllium husk 3400 powder

    • Formulation of: Plantago seed
    • Dosage form: Powder
    • Active ingredient moieties: Plantago seed
    Psyllium husk powder, for oral administration, consisting of: 3400mg/g plantago seed.Purpose:Bulk-forming laxative
    10.00
    1 votes
    73

    Titanium dioxide 0.235 powder

    • Formulation of: Titanium dioxide
    • Dosage form: Powder
    • Active ingredient moieties: Titanium dioxide
    Titanium dioxide powder, for cutaneous administration, consisting of: 0.235mg/mg titanium dioxide.
    10.00
    1 votes
    74
    6.50
    4 votes
    75

    Buprenorphine hydrochloride 8.64 tablet

    • Formulation of: Buprenorphine
    • Dosage form: Tablet
    • Active ingredient moieties: Buprenorphine
    Buprenorphine hydrochloride tablet, for sublingual administration, consisting of: 8.64mg/tablet buprenorphine hydrochloride.
    6.50
    4 votes
    76

    Calcitriol 1 injection

    • Formulation of: Calcitriol
    • Dosage form: Injectable
    • Active ingredient moieties: Calcitriol
    Calcitriol injection, for intravenous administration, consisting of: 1ug/mL calcitriol.
    6.50
    4 votes
    77

    Stavudine 40 capsule

    • Formulation of: Stavudine
    • Dosage form: Capsule
    • Active ingredient moieties: Stavudine
    Stavudine capsule, for oral administration, consisting of: 40mg/capsule stavudine.
    6.50
    4 votes
    78

    Triclosan 7.5 liquid

    • Formulation of: Triclosan
    • Dosage form: Liquid
    • Active ingredient moieties: Undecylenic acid
    Triclosan liquid, for topical administration, consisting of: 7.5mg/g triclosan.Purpose:Surgical Scrub Healthcare Personnel Handwash
    6.50
    4 votes
    79

    Arnica montana, hamamelis virginiana, rhus toxicodendron, 12/12/12 gel

    • Formulation of: Arnica montana/Hamamelis virginiana root bark/stem bark/Toxicodendron pubescens leaf homeopathic preparation
    • Dosage form: Gel
    • Active ingredient moieties: Arnica montana
    Arnica montana, hamamelis virginiana, rhus toxicodendron, gel, for topical administration, consisting of: 12[hp_X]/g arnica montana ; 12[hp_X]/g hamamelis virginiana root bark/stem bark ; 12[hp_X]/g toxicodendron pubescens leaf.Purpose: INDICATIONS: For temporary relief of minor symptoms of sore, overexerted muscles.
    8.50
    2 votes
    80

    Camphor and menthol 5/3.4 poultice

    • Formulation of: Camphor (natural)/Menthol
    • Dosage form: Poultice
    • Active ingredient moieties: Camphor (natural)
    Camphor and menthol poultice, for transdermal administration, consisting of: 5g camphor (natural) ; 3.4g menthol.Purpose: Purposes External Analgesic Uses For the temporary relief of minor aches and pains of muscles and joints due to:
    • simple backache
    • arthritis
    • strains
    • bruises
    • sprains
    8.50
    2 votes
    81

    Gel for burns 20 gel

    • Formulation of: Lidocaine
    • Dosage form: Gel
    • Active ingredient moieties: Lidocaine
    Gel for burns gel, for topical administration, consisting of: 20mg/mL lidocaine hydrochloride.Purpose:External analgesic
    8.50
    2 votes
    82

    Helium oxygen mixture 0.6/0.4 gas

    • Formulation of: Oxygen/Helium
    • Dosage form: Gas
    • Active ingredient moieties: Dioxygen
    Helium oxygen mixture gas, for respiratory (inhalation) administration, consisting of: 0.6mL/mL helium ; 0.4mL/mL oxygen.
    8.50
    2 votes
    83

    Red oak 20000 injectable solution

    • Formulation of: Quercus rubra pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Quercus rubra pollen
    Red oak injectable solution, for intradermal / subcutaneous administration, consisting of: 20000[PNU]/mL quercus rubra pollen.
    8.50
    2 votes
    84

    Sisal 20000 injectable solution

    • Formulation of: Agave sisalana fiber extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Agave sisalana fiber
    Sisal injectable solution, for intradermal / subcutaneous administration, consisting of: 20000[PNU]/mL agave sisalana fiber.
    8.50
    2 votes
    85

    Sucralfate 100 suspension

    • Formulation of: Sucralfate
    • Dosage form: Suspension
    • Active ingredient moieties: Sucralfate
    Sucralfate suspension, for oral administration, consisting of: 100mg/mL sucralfate.
    8.50
    2 votes
    86

    White petrolatum 0.57 paste

    • Formulation of: Petrolatum
    • Dosage form: Paste
    • Active ingredient moieties: Petrolatum
    White petrolatum paste, for topical administration, consisting of: 0.57mg/mg petrolatum.Purpose:Skin Protectant
    8.50
    2 votes
    87

    (morphine sulfate and naltrexone hydrochloride) extended release capsules 80/3.2 capsule

    • Formulation of: Morphine/naltrexone
    • Dosage form: Capsule
    • Active ingredient moieties: Morphine
    (morphine sulfate and naltrexone hydrochloride) extended release capsules capsule, for oral administration, consisting of: 80mg/capsule morphine sulfate ; 3.2mg/capsule naltrexone hydrochloride.Indications:EMBEDA is indicated for:
    • the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time (1)
    • EMBEDA is NOT intended for use as a prn analgesic
    7.33
    3 votes
    88

    Aconitum napellus, baptisia tinctoria root, black cohosh, bryonia alba root, chelidonium majus, conium maculatum flowering top, datura stramonium, delphinium staphisagria seed, gelsemium sempervirens root, gold, hypericum perforatum, lachesis muta venom,

    • Formulation of: Aconitum napellus/Silver cation/Gold/Baptisia tinctoria root/Bryonia alba root/Chelidonium majus/Black cohosh/Conium maculatum flowering top/Gelsemium sempervirens root/Strychnos ignatii seed/Potassium cation/Lachesis muta venom/Lilium lancifolium bulb/Ly
    • Dosage form: Pellet
    • Active ingredient moieties: Aconitum napellus
    Aconitum napellus, baptisia tinctoria root, black cohosh, bryonia alba root, chelidonium majus, conium maculatum flowering top, datura stramonium, delphinium staphisagria seed, gelsemium sempervirens root, gold, hypericum perforatum, lachesis muta venom, lead, lilium lancifolium bulb, lycopodium clavatum spore, matricaria recutita, phosphoric acid, phosphorus, potassium carbonate, sepia officinalis juice, silver nitrate, sodium carbonate, sodium chloride, strychnos ignatii seed, thuja occidentalis leafy twig, trinitrophenol, valerian, and zinc pellet, for oral administration, consisting of: 15[hp_X]/mg aconitum napellus ; 15[hp_X]/mg baptisia tinctoria root ; 15[hp_X]/mg black cohosh ; 15[hp_X]/mg bryonia alba root ; 15[hp_X]/mg chelidonium majus ; 15[hp_X]/mg conium maculatum flowering top ; 15[hp_X]/mg datura stramonium ; 15[hp_X]/mg delphinium staphisagria seed ; 15[hp_X]/mg gelsemium sempervirens root ; 15[hp_X]/mg gold ; 3[hp_X]/mg hypericum perforatum ; 15[hp_X]/mg lachesis muta venom ; 15[hp_X]/mg lead ; 15[hp_X]/mg lilium lancifolium bulb ; 15[hp_X]/mg lycopodium clavatum spore ; 3[hp_X]/mg matricaria recutita ; 15[hp_X]/mg phosphoric acid ; 15[hp_X]/mg phosphorus ; 15[hp_X]/mg potassium carbonate ; 15[hp_X]/mg sepia officinalis juice ; 15[hp_X]/mg silver nitrate ; 15[hp_X]/mg sodium carbonate ; 15[hp_X]/mg sodium chloride ; 15[hp_X]/mg strychnos ignatii seed ; 15[hp_X]/mg thuja occidentalis leafy twig ; 15[hp_X]/mg trinitrophenol ; 3[hp_X]/mg valerian ; 15[hp_X]/mg zinc.Purpose:Stress and Tension
    7.33
    3 votes
    89

    Desoximetasone 0.5 ointment

    • Formulation of: Desoximetasone
    • Dosage form: Ointment
    • Active ingredient moieties: Desoximetasone
    Desoximetasone ointment, for topical administration, consisting of: 0.5mg/g desoximetasone.
    7.33
    3 votes
    90
    7.33
    3 votes
    91

    Treatment set ts339754 800/0.002/0.002/0.002/400/16/4000/0.002/0.002/4000/0.002/0.002 injectable solution

    • Formulation of: Felis catus hair/Cynodon dactylon pollen/Sorghum halepense pollen/Poa pratensis pollen/Paspalum notatum pollen/Betula populifolia pollen/Populus deltoides pollen/Carya illinoinensis pollen/Ambrosia artemisiifolia pollen/Plantago lanceolata pollen/Festuca
    • Dosage form: Injectable solution
    • Active ingredient moieties: Felis catus hair
    Treatment set ts339754 injectable solution, for subcutaneous / intradermal administration, consisting of: 800[AU]/mL ambrosia artemisiifolia pollen ; 0.002g/mL betula populifolia pollen ; 0.002g/mL carya illinoinensis pollen ; 0.002g/mL carya tomentosa pollen ; 400[BAU]/mL cynodon dactylon pollen ; 16[BAU]/mL felis catus hair ; 4000[BAU]/mL festuca pratensis pollen ; 0.002g/mL paspalum notatum pollen ; 0.002g/mL plantago lanceolata pollen ; 4000[BAU]/mL poa pratensis pollen ; 0.002g/mL populus deltoides pollen ; 0.002g/mL sorghum halepense pollen.
    7.33
    3 votes
    92
    6.25
    4 votes
    93

    Oxygen-nitrogen mixture 800 gas

    • Formulation of: Dioxygen
    • Dosage form: Gas
    • Active ingredient moieties: Dioxygen
    Oxygen-nitrogen mixture gas, for respiratory (inhalation) administration, consisting of: 800mL/L oxygen.
    6.25
    4 votes
    94

    Propranolol hydrochloride 40 tablet

    • Formulation of: Propranolol
    • Dosage form: Tablet
    • Active ingredient moieties: Propranolol
    Propranolol hydrochloride tablet, for oral administration, consisting of: 40mg/tablet propranolol hydrochloride.
    6.25
    4 votes
    95

    Clove 18 tablet

    • Formulation of: Clove
    • Dosage form: Tablet
    • Active ingredient moieties: Clove
    Clove tablet, for oral administration, consisting of: 18mg/tablet clove.Purpose:improvement of vaginal discharge, leukorrhea, vperiod pain and menstrual irregularity
    7.00
    3 votes
    96

    Felbamate 400 tablet

    • Formulation of: Felbamate
    • Dosage form: Tablet
    • Active ingredient moieties: Felbamate
    Felbamate tablet, for oral administration, consisting of: 400mg/tablet felbamate.
    7.00
    3 votes
    97

    Mackerel 0.1 injectable solution

    • Formulation of: Mackerel, unspecified extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Mackerel
    Mackerel injectable solution, for intradermal / subcutaneous administration, consisting of: 0.1g/mL mackerel, unspecified.
    7.00
    3 votes
    98
    5.20
    5 votes
    99
    8.00
    2 votes
    100

    Dimethicone 50 cream

    • Formulation of: Polydimethylsiloxane
    • Dosage form: Cream
    • Active ingredient moieties: Polydimethylsiloxane
    Dimethicone cream, for topical administration, consisting of: 50uL/mL dimethicone.Purpose:Skin Protectant
    8.00
    2 votes
    101

    Fluticasone propionate and salmeterol 250/50 powder

    • Formulation of: Fluticasone/salmeterol
    • Dosage form: Powder
    • Active ingredient moieties: Salmeterol
    Fluticasone propionate and salmeterol powder, for respiratory (inhalation) administration, consisting of: 250ug fluticasone propionate ; 50ug salmeterol xinafoate.Indications:ADVAIR DISKUS is a combination product containing a corticosteroid and a LABA indicated for:
    • Treatment of asthma in patients aged 4 years and older. (1.1)
    • Maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). (1.2)
    Important limitation:
    • Not indicated for the relief of acute bronchospasm. (1.1, 1.2)
    8.00
    2 votes
    102

    Hoarse cough 30 pellet

    • Formulation of: Causticum homeopathic preparation
    • Dosage form: Pellet
    • Active ingredient moieties: Causticum
    Hoarse cough pellet, for oral administration, consisting of: 30[hp_C]/mL causticum.Purpose:Purpose: Hoarse cough
    8.00
    2 votes
    103

    Morphine sulfate 4 solution

    • Formulation of: Morphine
    • Dosage form: Solution
    • Active ingredient moieties: Morphine
    Morphine sulfate solution, for oral administration, consisting of: 4mg/mL morphine sulfate.Indications:Morphine sulfate is an opioid analgesic indicated for the relief of moderate to severe acute and chronic pain where an opioid analgesic is appropriate. (1) Morphine sulfate 100 mg per 5 mL (20 mg/mL) solution is indicated for the relief of moderate to severe acute and chronic pain in opioid-tolerant patients. (1)
    8.00
    2 votes
    104

    Octinoxate, titanium dioxide 0.034/0.01 lotion

    • Formulation of: Octinoxate/Titanium dioxide
    • Dosage form: Lotion
    • Active ingredient moieties: Octinoxate
    Octinoxate, titanium dioxide lotion, for topical administration, consisting of: 0.034mL/mL octinoxate ; 0.01mL/mL titanium dioxide.
    8.00
    2 votes
    105

    Olanzapine 2.5 tablet

    • Formulation of: Olanzapine
    • Dosage form: Tablet
    • Active ingredient moieties: Olanzapine
    Olanzapine tablet, for oral administration, consisting of: 2.5mg/tablet olanzapine.Indications:ZYPREXA® (olanzapine) is an atypical antipsychotic indicated: As oral formulation for the:
    • Treatment of schizophrenia. (1.1)
      • Adults: Efficacy was established in three clinical trials in patients with schizophrenia: two 6-week trials and one maintenance trial. (14.1)
      • Adolescents (ages 13-17): Efficacy was established in one 6-week trial in patients with schizophrenia (14.1). The increased potential (in adolescents compared with adults) for weight gain and hyperlipidemia may lead clinicians to consider prescribing other drugs first in adolescents. (1.1)
    • Acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. (1.2)
      • Adults: Efficacy was established in three clinical trials in patients with manic or mixed episodes of bipolar I disorder: two 3- to 4-week trials and one maintenance trial. (14.2)
      • Adolescents (ages 13-17): Efficacy was established in one 3-week trial in patients with manic or mixed episodes associated with bipolar I disorder (14.2). The increased potential (in adolescents compared with adults) for weight gain and hyperlipidemia may lead clinicians to consider prescribing other drugs first in adolescents. (1.2)
    • Medication therapy for pediatric patients with schizophrenia or bipolar I disorder should be undertaken only after a thorough diagnostic evaluation and with careful consideration of the potential risks. (1.3)
    • Adjunct to valproate or lithium in the treatment of manic or mixed episodes associated with bipolar I disorder. (1.2)
      • Efficacy was established in two 6-week clinical trials in adults (14.2). Maintenance efficacy has not been systematically evaluated.
    As ZYPREXA IntraMuscular for the:
    • Treatment of acute agitation associated with schizophrenia and bipolar I mania. (1.4)
      • Efficacy was established in three 1-day trials in adults. (14.3)
    As ZYPREXA and Fluoxetine in Combination for the:
    • Treatment of depressive episodes associated with bipolar I disorder. (1.5)
      • Efficacy was established with Symbyax (olanzapine and fluoxetine in combination) in adults; refer to the product label for Symbyax.
    • Treatment of treatment resistant depression (major depressive disorder in patients who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode). (1.6)
      • Efficacy was established with Symbyax (olanzapine and fluoxetine in combination) in adults; refer to the product label for Symbyax.
    8.00
    2 votes
    106

    Solifenacin succinate 10 film coated tablet

    • Formulation of: Solifenacin
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Solifenacin
    Solifenacin succinate film coated tablet, for oral administration, consisting of: 10mg/tablet solifenacin succinate.Indications:VESIcare is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency (1)
    8.00
    2 votes
    107

    Sulfamethoxazole and trimethoprim 80/16 injection

    • Formulation of: Sulfamethoxazole/Trimethoprim
    • Dosage form: Injectable
    • Active ingredient moieties: Sulfamethoxazole
    Sulfamethoxazole and trimethoprim injection, for intravenous administration, consisting of: 80mg/mL sulfamethoxazole ; 16mg/mL trimethoprim.
    8.00
    2 votes
    108

    Telmisartan 20 tablet

    • Formulation of: Telmisartan
    • Dosage form: Tablet
    • Active ingredient moieties: Telmisartan
    Telmisartan tablet, for oral administration, consisting of: 20mg/tablet telmisartan.Indications:MICARDIS is an angiotensin II receptor blocker (ARB) indicated for:
    • Treatment of hypertension (1.1)
    • Cardiovascular (CV) risk reduction in patients unable to take ACE inhibitors (1.2)
    8.00
    2 votes
    109

    Avobenzone, octinoxate 0.027/0.0675 lotion

    • Formulation of: Avobenzone/Octinoxate
    • Dosage form: Lotion
    • Active ingredient moieties: Avobenzone
    Avobenzone, octinoxate lotion, for topical administration, consisting of: 0.027mL/mL avobenzone ; 0.0675mL/mL octinoxate.
    9.00
    1 votes
    110
    9.00
    1 votes
    111

    Menthol 30 gel

    • Formulation of: Menthol
    • Dosage form: Gel
    • Active ingredient moieties: Menthol
    Menthol gel, for topical administration, consisting of: 30mg/mL menthol.Purpose:Topical analgesic
    9.00
    1 votes
    112
    9.00
    1 votes
    113

    Sulconazole nitrate 10 cream

    • Formulation of: Sulconazole
    • Dosage form: Cream
    • Active ingredient moieties: Sulconazole
    Sulconazole nitrate cream, for topical administration, consisting of: 10mg/g sulconazole nitrate.
    9.00
    1 votes
    114

    Arabica coffee bean 30 pellet

    • Formulation of: Arabica coffee bean homeopathic preparation
    • Dosage form: Pellet
    • Active ingredient moieties: Arabica coffee bean
    Arabica coffee bean pellet, for sublingual administration, consisting of: 30[hp_C]/pellet arabica coffee bean.Purpose:PURPOSE: SLEEP AID
    6.67
    3 votes
    115

    Chelidonium majus, cholesterinum, arsenicum album, belladonna, lycopodium clavatum, tarentula hispana, 1/1/3/30/1/10 liquid

    • Formulation of: Chelidonium majus/Cholesterol/Arsenic trioxide/Atropa belladonna/Lycopodium clavatum spore/Lycosa tarantula homeopathic preparation
    • Dosage form: Liquid
    • Active ingredient moieties: Greater celandine
    Chelidonium majus, cholesterinum, arsenicum album, belladonna, lycopodium clavatum, tarentula hispana, liquid, for oral administration, consisting of: 1[hp_M]/mL arsenic trioxide ; 1[hp_M]/mL atropa belladonna ; 3[hp_X]/mL chelidonium majus ; 30[hp_C]/mL cholesterol ; 1[hp_M]/mL lycopodium clavatum spore ; 10[hp_M]/mL lycosa tarantula.Purpose: INDICATIONS: For the temporary relief of anger and rage.
    6.67
    3 votes
    116

    Estradiol 0.05 extended release patch

    • Formulation of: Estradiol
    • Dosage form: Extended Release Patch
    • Active ingredient moieties: Estradiol
    Estradiol extended release patch, for transdermal administration, consisting of: 0.05mg/d estradiol.
    6.67
    3 votes
    117

    Firebush/burning bush 40000 injectable solution

    • Formulation of: Bassia scoparia pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Bassia scoparia pollen
    Firebush/burning bush injectable solution, for intradermal / subcutaneous administration, consisting of: 40000[PNU]/mL bassia scoparia pollen.
    6.67
    3 votes
    118

    Titanium dioxide, zinc oxide 0.126/0.02 cream

    • Formulation of: Titanium dioxide/Zinc oxide
    • Dosage form: Cream
    • Active ingredient moieties: Titanium dioxide
    Titanium dioxide, zinc oxide cream, for topical administration, consisting of: 0.126mL/mL titanium dioxide ; 0.02mL/mL zinc oxide.
    6.67
    3 votes
    119
    5.75
    4 votes
    120

    Diphenhydramine hydrochloride 2.5 liquid

    • Formulation of: Diphenhydramine
    • Dosage form: Liquid
    • Active ingredient moieties: Diphenhydramine
    Diphenhydramine hydrochloride liquid, for oral administration, consisting of: 2.5mg/mL diphenhydramine hydrochloride.Purpose:Purpose: Antihistamine
    5.75
    4 votes
    121
    5.75
    4 votes
    122

    Titanium dioxide 0.05 powder

    • Formulation of: Titanium dioxide
    • Dosage form: Powder
    • Active ingredient moieties: Titanium dioxide
    Titanium dioxide powder, for topical administration, consisting of: 0.05mg/mg titanium dioxide.Purpose:sunscreen
    5.75
    4 votes
    123

    .alpha.-tocopherol, ascophyllum nodosum, botryoglossum platycarpum, fucus serratus, fucus vesiculosus, isoleucine, laminaria digitata, leucine, pork collagen, retinol, selenium, sus scrofa capillary tissue, sus scrofa placenta, sus scrofa skin, ubidecaren

    • Formulation of: .alpha.-tocopherol/Laminaria digitata/Botryoglossum platycarpum/Fucus serratus/Sus scrofa capillary tissue/Ubidecarenone/Pork collagen/Fucus vesiculosus/Isoleucine/Ascophyllum nodosum/Leucine/Sus scrofa placenta/Retinol/Ulva lactuca/Selenium/Sus scrofa sk
    • Dosage form: Pellet
    • Active ingredient moieties: Alpha-Tocopherol
    .alpha.-tocopherol, ascophyllum nodosum, botryoglossum platycarpum, fucus serratus, fucus vesiculosus, isoleucine, laminaria digitata, leucine, pork collagen, retinol, selenium, sus scrofa capillary tissue, sus scrofa placenta, sus scrofa skin, ubidecarenone, and ulva lactuca pellet, for oral administration, consisting of: 0.001[hp_C]/mg .alpha.-tocopherol ; 0.001[hp_C]/mg ascophyllum nodosum ; 0.001[hp_C]/mg botryoglossum platycarpum ; 0.001[hp_C]/mg fucus serratus ; 0.001[hp_C]/mg fucus vesiculosus ; 0.001[hp_C]/mg isoleucine ; 0.001[hp_C]/mg laminaria digitata ; 0.001[hp_C]/mg leucine ; 0.001[hp_C]/mg pork collagen ; 0.001[hp_C]/mg retinol ; 0.001[hp_C]/mg selenium ; 0.001[hp_C]/mg sus scrofa capillary tissue ; 0.001[hp_C]/mg sus scrofa placenta ; 0.001[hp_C]/mg sus scrofa skin ; 0.001[hp_C]/mg ubidecarenone ; 0.001[hp_C]/mg ulva lactuca.
    7.50
    2 votes
    124

    Barley malt 50 injectable solution

    • Formulation of: Barley malt extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Barley malt
    Barley malt injectable solution, for percutaneous / subcutaneous administration, consisting of: 50mg/mL barley malt.
    7.50
    2 votes
    125

    Benzalkonium chloride 1.3 liquid

    • Formulation of: Benzalkonium
    • Dosage form: Liquid
    • Active ingredient moieties: Benzalkonium
    Benzalkonium chloride liquid, for topical administration, consisting of: 1.3mL/mL benzalkonium chloride.Purpose:
    • For the relive of symtoms associated with sore throat including:
    pain, Burning, Itching and tingling
    • First aid to help guard against secondary skin infection due to sore
      throat.







    7.50
    2 votes
    126

    Black locust 0.1 injectable solution

    • Formulation of: Robinia pseudoacacia pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Robinia pseudoacacia pollen
    Black locust injectable solution, for intradermal / subcutaneous administration, consisting of: 0.1g/mL robinia pseudoacacia pollen.
    7.50
    2 votes
    127
    7.50
    2 votes
    128

    Emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 200/27.5/300 film coated tablet

    • Formulation of: Emtricitabine/rilpivirine/tenofovir
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Emtricitabine
    Emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate film coated tablet, for oral administration, consisting of: 200mg/tablet emtricitabine ; 27.5mg/tablet rilpivirine hydrochloride ; 300mg/tablet tenofovir disoproxil fumarate.Indications:COMPLERA, a combination of 2 nucleoside analog HIV-1 reverse transcriptase inhibitors (emtricitabine and tenofovir disoproxil fumarate) and 1 non-nucleoside reverse transcriptase inhibitor (rilpivirine), is indicated for use as a complete regimen for the treatment of HIV-1 infection in treatment-naive adults. (1) The following points should be considered when initiating therapy with COMPLERA:
    • More rilpivirine-treated subjects with HIV-1 RNA greater than 100,000 copies/mL at the start of therapy experienced virologic failure compared to subjects with HIV-1 RNA less than 100,000 copies/mL at the start of therapy.
    • The observed virologic failure rate in rilpivirine-treated subjects conferred a higher rate of overall treatment resistance and cross-resistance to the NNRTI class compared to efavirenz.
    • More subjects treated with rilpivirine developed lamivudine/emtricitabine associated resistance compared to efavirenz. (1, 12.4, 14)
    • COMPLERA is not recommended for patients less than 18 years of age. (8.4)
    7.50
    2 votes
    129

    Ethyl alcohol 65 cloth

    • Formulation of: Ethanol
    • Dosage form: Cloth
    • Active ingredient moieties: Ethanol
    Ethyl alcohol cloth, for topical administration, consisting of: 65mL alcohol.Purpose:Antiseptic Handwash
    7.50
    2 votes
    130
    7.50
    2 votes
    131

    Mesalamine 66.667 kit

    • Formulation of: Mesalamine
    • Dosage form: Drug Kit
    • Active ingredient moieties: Mesalamine
    Mesalamine kit, for rectal / topical administration, consisting of: 66.667mg/mL mesalamine.
    7.50
    2 votes
    132

    Octinoxate 0.06 lotion

    • Formulation of: Octinoxate/Octisalate/Titanium dioxide
    • Dosage form: Lotion
    • Active ingredient moieties: Octinoxate
    Octinoxate lotion, for topical administration, consisting of: 0.06mL/mL octinoxate ; 0.04mL/mL octisalate ; 0.043mL/mL titanium dioxide.Purpose:Provides SPF 15 sun protection.
    7.50
    2 votes
    133

    Phentermine hydrochloride 30 capsule

    • Formulation of: Phentermine
    • Dosage form: Capsule
    • Active ingredient moieties: Phentermine
    Phentermine hydrochloride capsule, for oral administration, consisting of: 30mg/capsule phentermine hydrochloride.
    7.50
    2 votes
    134

    Triclosan 0.00025 liquid

    • Formulation of: Triclosan
    • Dosage form: Liquid
    • Active ingredient moieties: Undecylenic acid
    Triclosan liquid, for topical administration, consisting of: 0.00025mL/mL triclosan.Purpose:UsesFor handwashing to decrease bacteria on the skin
    7.50
    2 votes
    135

    Acarbose 100 tablet

    • Formulation of: Acarbose
    • Dosage form: Tablet
    • Active ingredient moieties: Acarbose
    Acarbose tablet, for oral administration, consisting of: 100mg/tablet acarbose.
    6.33
    3 votes
    136

    Aliskiren hemifumarate and valsartan 300/320 film coated tablet

    • Formulation of: Aliskiren/Valsartan
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Aliskiren
    Aliskiren hemifumarate and valsartan film coated tablet, for oral administration, consisting of: 300mg/tablet aliskiren hemifumarate ; 320mg/tablet valsartan.Indications:Valturna is a combination of aliskiren, a renin inhibitor, and valsartan, an angiotensin II receptor blocker (ARB), indicated for the treatment of hypertension, to lower blood pressure:
    • In patients not adequately controlled with monotherapy. (1)
    • May be substituted for titrated components. (1)
    • As initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals. (1)
    Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
    6.33
    3 votes
    137

    Carvedilol 6.25 coated tablet

    • Formulation of: Carvedilol
    • Dosage form: Coated tablet
    • Active ingredient moieties: Carvedilol
    Carvedilol coated tablet, for oral administration, consisting of: 6.25mg/tablet carvedilol.Indications:Carvedilol is an alpha/beta-adrenergic blocking agent indicated for the treatment of:
    • Left ventricular dysfunction following myocardial infarction in clinically stable patients (1.1)
    • Hypertension (1.2)
    6.33
    3 votes
    138

    Pegvisomant 10 kit

    • Formulation of: Pegvisomant
    • Dosage form: Drug Kit
    • Active ingredient moieties: Pegvisomant
    Pegvisomant kit, for subcutaneous administration, consisting of: 10mg/mL pegvisomant.
    6.33
    3 votes
    139

    Alprazolam 1 concentrate solution

    • Formulation of: Alprazolam
    • Dosage form: Concentrate solution
    • Active ingredient moieties: Alprazolam
    Alprazolam concentrate solution, for oral administration, consisting of: 1mg/mL alprazolam.
    8.00
    1 votes
    140

    Clozapine 200 tablet

    • Formulation of: Clozapine
    • Dosage form: Tablet
    • Active ingredient moieties: Clozapine
    Clozapine tablet, for oral administration, consisting of: 200mg/tablet clozapine.
    8.00
    1 votes
    141

    Ethanol 693 liquid

    • Formulation of: Ethanol
    • Dosage form: Liquid
    • Active ingredient moieties: Ethanol
    Ethanol liquid, for topical administration, consisting of: 693mg/mL alcohol.Purpose:Hand Sanitizer
    8.00
    1 votes
    142
    8.00
    1 votes
    143

    Thymus extract 3 liquid

    • Formulation of: Bos taurus thymus homeopathic preparation
    • Dosage form: Liquid
    • Active ingredient moieties: Bos taurus thymus
    Thymus extract liquid, for oral administration, consisting of: 3[hp_X]/mL bos taurus thymus.
    8.00
    1 votes
    144

    Triamcinolone diacetate 40 injection

    • Formulation of: Triamcinolone
    • Dosage form: Injectable
    • Active ingredient moieties: Triamcinolone
    Triamcinolone diacetate injection, for intramuscular administration, consisting of: 40mg/mL triamcinolone diacetate.
    8.00
    1 votes
    145

    Treatment set ts339813 0.002/4000/0.002/400/0.002/0.002 injectable solution

    • Formulation of: Alternaria alternata/Felis catus hair/Canis lupus familiaris hair/Juniperus ashei pollen/Ambrosia artemisiifolia pollen/Iva annua pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Alternaria alternata
    Treatment set ts339813 injectable solution, for intradermal / subcutaneous administration, consisting of: 0.002g/mL alternaria alternata ; 4000[AU]/mL ambrosia artemisiifolia pollen ; 0.002g/mL canis lupus familiaris hair ; 400[BAU]/mL felis catus hair ; 0.002g/mL iva annua pollen ; 0.002g/mL juniperus ashei pollen.
    5.25
    4 votes
    146

    Ambrisentan 5 film coated tablet

    • Formulation of: Ambrisentan
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Ambrisentan
    Ambrisentan film coated tablet, for oral administration, consisting of: 5mg/tablet ambrisentan.Indications:LETAIRIS is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability and delay clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (64%) or PAH associated with connective tissue diseases (32%) (1).
    7.00
    2 votes
    147
    7.00
    2 votes
    148

    Niacin, melatonin, nadidum, pyridoxinum hydrochloricum, zincum sulphuricum, hypothalamus, lithium carbonicum, magnesia carbonica, pineal, pituitary, 8/8/6/6/3/6/8/8/8/6 spray

    • Formulation of: Niacin/Melatonin/Nadide/Pyridoxine/Zinc cation/Sus scrofa hypothalamus/Lithium cation/Magnesium cation/Sus scrofa pineal gland/Sus scrofa pituitary gland homeopathic preparation
    • Dosage form: Spray
    • Active ingredient moieties: Niacin
    Niacin, melatonin, nadidum, pyridoxinum hydrochloricum, zincum sulphuricum, hypothalamus, lithium carbonicum, magnesia carbonica, pineal, pituitary, spray, for oral administration, consisting of: 8[hp_X]/mL lithium carbonate ; 8[hp_X]/mL magnesium carbonate ; 6[hp_X]/mL melatonin ; 6[hp_X]/mL nadide ; 3[hp_X]/mL niacin ; 6[hp_X]/mL pyridoxine hydrochloride ; 8[hp_X]/mL sus scrofa hypothalamus ; 8[hp_X]/mL sus scrofa pineal gland ; 8[hp_X]/mL sus scrofa pituitary gland ; 6[hp_X]/mL zinc sulfate heptahydrate.Purpose: INDICATIONS: For temporary relief of imbalances in menstruation and ovulation, insomnia, dysmenorrhea and imbalance in menstrual cycle.
    7.00
    2 votes
    149

    Polymyxin b sulfate 500000 powder for injectable solution

    • Formulation of: Polymyxin B
    • Dosage form: Powder For Injectable Solution
    • Active ingredient moieties: Polymyxin B
    Polymyxin b sulfate powder for injectable solution, for intramuscular / intrathecal / intravenous / ophthalmic administration, consisting of: 500000units/vial polymyxin b sulfate.
    7.00
    2 votes
    150

    Privet 10000 injectable solution

    • Formulation of: Ligustrum vulgare pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Ligustrum vulgare pollen
    Privet injectable solution, for intradermal / subcutaneous administration, consisting of: 10000[PNU]/mL ligustrum vulgare pollen.
    7.00
    2 votes
    151
    7.00
    2 votes
    152

    Reteplase 1.81 kit

    • Formulation of: Reteplase
    • Dosage form: Drug Kit
    • Active ingredient moieties: Reteplase
    Reteplase kit, for intravenous administration, consisting of: 1.81mg/mL reteplase.
    7.00
    2 votes
    153

    Ropinirole hydrochloride 6 extended release film coated tablet

    • Formulation of: Ropinirole
    • Dosage form: Extended release film coated tablet
    • Active ingredient moieties: Ropinirole
    Ropinirole hydrochloride extended release film coated tablet, for oral administration, consisting of: 6mg/tablet ropinirole hydrochloride.Indications:REQUIP XL is an orally administered, non-ergoline dopamine agonist indicated for the treatment of signs and symptoms of idiopathic Parkinson’s disease. (1.1)
    7.00
    2 votes
    154

    Salicylic acid 0.0047 liquid

    • Formulation of: Salicylic acid
    • Dosage form: Liquid
    • Active ingredient moieties: Octinoxate
    Salicylic acid liquid, for topical administration, consisting of: 0.0047mL/mL salicylic acid.Purpose:helps to clear dead cells and sebum that may block skin pores
    7.00
    2 votes
    155

    Zinc oxide 0.091 powder

    • Formulation of: Zinc
    • Dosage form: Powder
    • Active ingredient moieties: Zinc
    Zinc oxide powder, for topical administration, consisting of: 0.091mg/mg zinc oxide.Purpose:Skin protectant powder
    7.00
    2 votes
    156

    Dog hair 0.05 injectable solution

    • Formulation of: Canis lupus familiaris hair extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Canis lupus familiaris hair
    Dog hair injectable solution, for subcutaneous / intradermal administration, consisting of: 0.05g/mL canis lupus familiaris hair.
    6.00
    3 votes
    157

    Methyl salicylate, menthol and capsaicin 0.3/0.1/0.000375 lotion

    • Formulation of: Salicylic acid/Menthol/Capsaicin
    • Dosage form: Lotion
    • Active ingredient moieties: Salicylic acid
    Methyl salicylate, menthol and capsaicin lotion, for topical administration, consisting of: 0.000375mL/mL capsaicin ; 0.1mL/mL menthol ; 0.3mL/mL methyl salicylate.Purpose:Topical Analgesic
    6.00
    3 votes
    158

    Natural medicine 0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169/0.169 liquid

    • Formulation of: Horse chestnut/Arnica montana/Bellis perennis/Bryonia alba root/Oyster shell calcium carbonate, crude/Calcium fluoride/Black cohosh/Cobalt/Pseudognaphalium obtusifolium/Hypericum perforatum/Potassium cation/Magnesium cation/Oxalic acid/Phosphorus/Toxicode
    • Dosage form: Liquid
    • Active ingredient moieties: Common Horse-chestnut
    Natural medicine liquid, for oral administration, consisting of: 0.169[hp_X]/mL arnica montana ; 0.169[hp_X]/mL bellis perennis ; 0.169[hp_X]/mL black cohosh ; 0.169[hp_X]/mL bryonia alba root ; 0.169[hp_X]/mL calcium fluoride ; 0.169[hp_X]/mL cobalt ; 0.169[hp_X]/mL horse chestnut ; 0.169[hp_X]/mL hypericum perforatum ; 0.169[hp_X]/mL magnesium phosphate, dibasic trihydrate ; 0.169[hp_X]/mL oxalic acid ; 0.169[hp_X]/mL oyster shell calcium carbonate, crude ; 0.169[hp_X]/mL phosphorus ; 0.169[hp_X]/mL potassium carbonate ; 0.169[hp_X]/mL potassium phosphate, dibasic ; 0.169[hp_X]/mL pseudognaphalium obtusifolium ; 0.169[hp_X]/mL ruta graveolens flowering top ; 0.169[hp_X]/mL toxicodendron pubescens leaf ; 0.169[hp_X]/mL zinc.Purpose: HPUS active ingredients                                                 Purpose Equal volumes of each ingredient in 10X, 30X and LM1 potencies. Aesculus hippocastanum...................................................Weakness, tired feet
    Arnica montana.................................................................body aches, restlessness
    Bellis perennis...................................................................muscular soreness, sprains
    Bryonia.............................................................................stiff and swollen joints
    Calcarea carbonica............................................................back pain, stiff neck
    Calcarea fluorica................................................................malnutrition of bones
    Cimicifuga racemosa..........................................................back and leg pain
    Cobaltum metallicum...........................................................fatigue, bone pain
    Gnaphalium polycephalum..................................................leg cramps, numbness
    Hypericum perforatum........................................................nerve injury, acute pain
    Kali carbonicum..................................................................muscle tension and stiffness
    Kali Phosphoricum..............................................................tired legs and back
    Magnesia phosphorica........................................................muscle spasms, exhaustion
    Oxalicum acidum................................................................radiating pain, tingling
    Phosphorus........................................................................weak joints, trembling
    Rhus toxicodendron............................................................strained tendons and joints
    Ruta graveolens.................................................................body aches, sprains
    Zincum metallicum..............................................................tissue damage, spinal pain
    Reference image of back.jpg
    6.00
    3 votes
    159

    Octinoxate zinc oxide 0.075/0.06 cream

    • Formulation of: Zinc oxide/Octinoxate
    • Dosage form: Cream
    • Active ingredient moieties: Octinoxate
    Octinoxate zinc oxide cream, for topical administration, consisting of: 0.075mg/mg octinoxate ; 0.06mg/mg zinc oxide.Purpose:PURPOSE:
    SUNSCREEN
    6.00
    3 votes
    160

    Skin conditioner 0.03 lotion

    • Formulation of: Polydimethylsiloxane
    • Dosage form: Lotion
    • Active ingredient moieties: Polydimethylsiloxane
    Skin conditioner lotion, for topical administration, consisting of: 0.03mg/mL dimethicone.Purpose:Skin Protectant
    6.00
    3 votes
    161

    Trichoderma harzianam 40000 injectable solution

    • Formulation of: Trichoderma harzianum extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Trichoderma harzianum
    Trichoderma harzianam injectable solution, for subcutaneous / intradermal administration, consisting of: 40000[PNU]/mL trichoderma harzianum.
    6.00
    3 votes
    162

    Trichothecium roseum 0.1 injectable solution

    • Formulation of: Trichothecium roseum extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Trichothecium roseum
    Trichothecium roseum injectable solution, for subcutaneous / intradermal administration, consisting of: 0.1g/mL trichothecium roseum.
    6.00
    3 votes
    163

    Zinc oxide 200 lotion

    • Formulation of: Zinc oxide
    • Dosage form: Lotion
    • Active ingredient moieties: Zinc
    Zinc oxide lotion, for topical administration, consisting of: 200mg/g zinc oxide.Purpose:Sunscreen
    6.00
    3 votes
    164

    Candida albicans, 60 liquid

    • Formulation of: Candida albicans homeopathic preparation
    • Dosage form: Liquid
    • Active ingredient moieties: Candida albicans
    Candida albicans, liquid, for oral administration, consisting of: 60[hp_X]/mL candida albicans.Purpose: INDICATIONS: For temporary relief of gas with abdominal discomfort after eating, mood swings, joint pains, irritability, forgetfulness, skin rashes, and fatigue.
    6.50
    2 votes
    165
    6.50
    2 votes
    166

    Hydroxyproline 0.005 cream

    • Formulation of: Hydroxyproline
    • Dosage form: Cream
    • Active ingredient moieties: Hydroxyproline
    Hydroxyproline cream, for topical administration, consisting of: 0.005/mL hydroxyproline.
    6.50
    2 votes
    167

    Isotretinoin 40 liquid filled capsule

    • Formulation of: Isotretinoin
    • Dosage form: Liquid Filled Capsule
    • Active ingredient moieties: Isotretinoin
    Isotretinoin liquid filled capsule, for oral administration, consisting of: 40mg/capsule isotretinoin.
    6.50
    2 votes
    168

    Meperidine hydrochloride 10 injectable solution

    • Formulation of: Meperidine Hydrochloride
    • Dosage form: Injectable solution
    • Active ingredient moieties: Pethidine
    Meperidine hydrochloride injectable solution, for intravenous administration, consisting of: 10mg/mL meperidine hydrochloride.
    6.50
    2 votes
    169
    6.50
    2 votes
    170

    Sodium chloride, sodium acetate anhydrous, sodium gluconate, potassium chloride, and magnesium chloride 5.26/2.22/5.02/0.37/0.3 injectable solution

    • Formulation of: Sodium cation/Potassium cation/Magnesium cation
    • Dosage form: Injectable solution
    • Active ingredient moieties: Sodium
    Sodium chloride, sodium acetate anhydrous, sodium gluconate, potassium chloride, and magnesium chloride injectable solution, for intravenous administration, consisting of: 0.3mg/mL magnesium chloride ; 0.37mg/mL potassium chloride ; 2.22mg/mL sodium acetate anhydrous ; 5.26mg/mL sodium chloride ; 5.02mg/mL sodium gluconate.
    6.50
    2 votes
    171

    Tuna 50 injectable solution

    • Formulation of: Tuna, unspecified extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Tuna
    Tuna injectable solution, for percutaneous / subcutaneous administration, consisting of: 50mg/mL tuna, unspecified.
    6.50
    2 votes
    172

    Cochliobolus spicifer, helminthosporium solani, khuskia oryzae, microascus brevicaulis, mycogone nigra, myrothecium verrucaria, neurospora crassa, paecilomyces variotii, passalora fulva, pleospora tarda, streptomyces griseus, trichoderma viride, trichophy

    • Formulation of: Trichothecium roseum/Passalora fulva/Cochliobolus spicifer/Myrothecium verrucaria/Trichophyton schoenleinii/Mycogone nigra/Neurospora crassa/Khuskia oryzae/Paecilomyces variotii/Microascus brevicaulis/Helminthosporium solani/Pleospora tarda/Streptomyces g
    • Dosage form: Injectable solution
    • Active ingredient moieties: Trichothecium roseum
    Cochliobolus spicifer, helminthosporium solani, khuskia oryzae, microascus brevicaulis, mycogone nigra, myrothecium verrucaria, neurospora crassa, paecilomyces variotii, passalora fulva, pleospora tarda, streptomyces griseus, trichoderma viride, trichophyton schoenleinii, and trichothecium roseum injectable solution, for percutaneous / subcutaneous administration, consisting of: 3.55mg/mL cochliobolus spicifer ; 3.6mg/mL helminthosporium solani ; 3.55mg/mL khuskia oryzae ; 3.6mg/mL microascus brevicaulis ; 3.55mg/mL mycogone nigra ; 3.55mg/mL myrothecium verrucaria ; 3.55mg/mL neurospora crassa ; 3.6mg/mL paecilomyces variotii ; 3.55mg/mL passalora fulva ; 3.6mg/mL pleospora tarda ; 3.6mg/mL streptomyces griseus ; 3.6mg/mL trichoderma viride ; 3.55mg/mL trichophyton schoenleinii ; 3.55mg/mL trichothecium roseum.
    4.75
    4 votes
    173
    7.00
    1 votes
    174

    Benzalkonium chloride, benzocaine, sd alcohol, bacitracin zinc, neomycin sulfate, polymyxin b, ibuprofen, acetaminophen 325/0.6/400/0.004,0.0013/0.06/200/0.005/5/5000 kit

    • Formulation of: Benzalkonium/Benzocaine/Alcohol/Bacitracin/Neomycin/Polymyxin b/Acetaminophen/Ibuprofen/Lidocaine
    • Dosage form: Drug Kit
    • Active ingredient moieties: Benzalkonium
    Benzalkonium chloride, benzocaine, sd alcohol, bacitracin zinc, neomycin sulfate, polymyxin b, ibuprofen, acetaminophen kit, for topical / oral administration, consisting of: 325mg acetaminophen ; 0.6mL/mL alcohol ; 400[iU]/g bacitracin zinc ; 0.004mL/mL,0.0013mg/mg benzalkonium chloride ; 0.06mL/mL benzocaine ; 200mg ibuprofen ; 0.005mg/mg lidocaine ; 5mg/g neomycin sulfate ; 5000[iU]/g polymyxin b sulfate.Purpose:
    Antiseptic
    7.00
    1 votes
    175

    Benzocaine,alcohol 0.06/0.6 swab

    • Formulation of: Benzocaine/Alcohol
    • Dosage form: Swab
    • Active ingredient moieties: Benzocaine
    Benzocaine,alcohol swab, for topical administration, consisting of: 0.6mL/swab alcohol ; 0.06mL/swab benzocaine.
    7.00
    1 votes
    176

    Bermuda grass, standardized 10000 injectable solution

    • Formulation of: Cynodon dactylon pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Cynodon dactylon pollen
    Bermuda grass, standardized injectable solution, for subcutaneous administration, consisting of: 10000[BAU]/mL cynodon dactylon pollen.
    7.00
    1 votes
    177

    Clarithromycin 50 granule for suspension

    • Formulation of: Clarithromycin
    • Dosage form: Granule for suspension
    • Active ingredient moieties: Clarithromycin
    Clarithromycin granule for suspension, for oral administration, consisting of: 50mg/mL clarithromycin.
    7.00
    1 votes
    178

    Cocoa butter, phenylephrine hcl 0.8/0.0296 suppository

    • Formulation of: Cocoa butter/Phenylephrine
    • Dosage form: Suppository
    • Active ingredient moieties: Cocoa butter
    Cocoa butter, phenylephrine hcl suppository, for rectal administration, consisting of: 0.8mg/mg cocoa butter ; 0.0296mg/mg phenylephrine hydrochloride.Purpose:Protectant Vasoconstrictor
    7.00
    1 votes
    179

    Doxycycline 100 film coated tablet

    • Formulation of: Doxycycline
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Doxycycline
    Doxycycline film coated tablet, for oral administration, consisting of: 100mg/tablet doxycycline.
    7.00
    1 votes
    180

    Menthol, methyl salicylate 0.025/0.1 cream

    • Formulation of: Menthol/Methyl salicylate
    • Dosage form: Cream
    • Active ingredient moieties: Menthol
    Menthol, methyl salicylate cream, for topical administration, consisting of: 0.025mg/mg menthol ; 0.1mg/mg methyl salicylate.Purpose:Purpose :  External Analgesic
    7.00
    1 votes
    181

    Psyllium husk 0.309 powder

    • Formulation of: Psyllium seed husks
    • Dosage form: Powder
    • Active ingredient moieties: Psyllium seed husks
    Psyllium husk powder, for oral administration, consisting of: 0.309mg/mg psyllium husk.Purpose:Fiber therapy for regularity
    7.00
    1 votes
    182

    Treatment set ts338618 10000/2000/2000/0.005/0.05/20000 injectable solution

    • Formulation of: Felis catus hair/Cynodon dactylon pollen/Phleum pratense pollen/Ambrosia artemisiifolia pollen/Iva annua pollen/Fraxinus americana pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Felis catus hair
    Treatment set ts338618 injectable solution, for subcutaneous / intradermal administration, consisting of: 10000[AU]/mL ambrosia artemisiifolia pollen ; 2000[BAU]/mL cynodon dactylon pollen ; 2000[BAU]/mL felis catus hair ; 0.005g/mL fraxinus americana pollen ; 0.05g/mL iva annua pollen ; 20000[BAU]/mL phleum pratense pollen.
    7.00
    1 votes
    183

    Venlafaxine hydrochloride 37.5 extended release tablet

    • Formulation of: Venlafaxine
    • Dosage form: Extended release tablet
    • Active ingredient moieties: Venlafaxine
    Venlafaxine hydrochloride extended release tablet, for oral administration, consisting of: 37.5mg/tablet venlafaxine hydrochloride.Indications:Venlafaxine Extended Release Tablets are a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for:
    • Major Depressive Disorder (MDD) (1.1)
    • Social Anxiety Disorder (SAD) (1.2)
    7.00
    1 votes
    184

    Amlodipine besylate and benazepril hydrochloride 5/10 capsule

    • Formulation of: Amlodipine/benazepril
    • Dosage form: Capsule
    • Active ingredient moieties: Amlodipine
    Amlodipine besylate and benazepril hydrochloride capsule, for oral administration, consisting of: 5mg/capsule amlodipine besylate ; 10mg/capsule benazepril hydrochloride.Indications:Lotrel is a combination tablet of amlodipine, a dihydropyridine calcium channel blocker (DHP CCB) and benazepril, an angiotensin converting enzyme (ACE) inhibitor. Lotrel is indicated for the treatment of hypertension (1) in patients not adequately controlled on monotherapy with either agent
    6.00
    2 votes
    185

    Astragalus membranaceus, echinacea angustifolia 3/12/12/3/30/12/3/30/3/30/30/3/30/8 liquid

    • Formulation of: Echinacea angustifolia/Goldenseal/Smilax regelii root/Tabebuia impetiginosa bark/Thyroid, unspecified/Gold/Causticum/Sodium cation/Gelsemium sempervirens root/Phosphorus/Sulfur/Thuja occidentalis leafy twig/Astragalus propinquus root/Carbo animalis homeop
    • Dosage form: Liquid
    • Active ingredient moieties: Echinacea angustifolia
    Astragalus membranaceus, echinacea angustifolia liquid, for oral administration, consisting of: 3[hp_X]/mL astragalus propinquus root ; 12[hp_X]/mL carbo animalis ; 12[hp_X]/mL causticum ; 3[hp_X]/mL echinacea angustifolia ; 30[hp_X]/mL gelsemium sempervirens root ; 12[hp_X]/mL gold ; 3[hp_X]/mL goldenseal ; 30[hp_X]/mL phosphorus ; 3[hp_X]/mL smilax regelii root ; 30[hp_X]/mL sodium sulfate ; 30[hp_X]/mL sulfur ; 3[hp_X]/mL tabebuia impetiginosa bark ; 30[hp_X]/mL thuja occidentalis leafy twig ; 8[hp_X]/mL thyroid, unspecified.Purpose: Indications: For temporary relief of chills up and down back; extremities heavy, ache at night; general exhaustion; dry, hard cough with weakness in the chest.
    6.00
    2 votes
    186

    Capecitabine 150 film coated tablet

    • Formulation of: Capecitabine
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Capecitabine
    Capecitabine film coated tablet, for oral administration, consisting of: 150mg/tablet capecitabine.Indications:XELODA (capecitabine) is a nucleoside metabolic inhibitor with antineoplastic activity indicated for:
    • Adjuvant Colon Cancer (1.1)
      • Patients with Dukes' C colon cancer
    • Metastatic Colorectal Cancer (1.1)
      • First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred
    • Metastatic Breast Cancer (1.2)
      • In combination with docetaxel after failure of prior anthracycline-containing therapy
      • As monotherapy in patients resistant to both paclitaxel and an anthracycline-containing regimen
    6.00
    2 votes
    187

    Degarelix 40 metered powder

    • Formulation of: Degarelix
    • Dosage form: Metered powder
    • Active ingredient moieties: Degarelix
    Degarelix metered powder, for subcutaneous administration, consisting of: 40mg/mL degarelix acetate.Indications:FIRMAGON is a GnRH receptor antagonist indicated for treatment of patients with advanced prostate cancer. (1)
    6.00
    2 votes
    188

    Dermatophagoides farinae 10000 concentrate

    • Formulation of: Dermatophagoides farinae extract
    • Dosage form: Concentrate
    • Active ingredient moieties: Dermatophagoides farinae
    Dermatophagoides farinae concentrate, for percutaneous / intradermal / subcutaneous administration, consisting of: 10000[AU]/mL dermatophagoides farinae.Indications:Greer Standardized Mite Extracts are allergenic extracts indicated for
    • Diagnosis of skin test reactivity to dust mite allergen (1)
    • Treatment of mite-induced allergic asthma, rhinitis and conjunctivitis in patients that show hypersensitivity to dust mites based on clinical history, allergen exposure history, and skin test reactivity (1)
    6.00
    2 votes
    189

    Famotidine 40 tablet

    • Formulation of: Famotidine
    • Dosage form: Tablet
    • Active ingredient moieties: Famotidine
    Famotidine tablet, for oral administration, consisting of: 40mg/tablet famotidine.
    6.00
    2 votes
    190

    Japanese black pine 0.05 injectable solution

    • Formulation of: Pinus thunbergii pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Pinus thunbergii pollen
    Japanese black pine injectable solution, for subcutaneous / intradermal administration, consisting of: 0.05g/mL pinus thunbergii pollen.
    6.00
    2 votes
    191

    Ribavirin 200 film coated tablet

    • Formulation of: Ribavirin
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Ribavirin
    Ribavirin film coated tablet, for oral administration, consisting of: 200mg/tablet ribavirin.Indications:Ribasphere (ribavirin, USP) is a nucleoside analogue indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with peginterferon alfa-2a in adults with compensated liver disease not previously treated with interferon alpha, and in CHC patients coinfected with HIV (1)
    6.00
    2 votes
    192

    Sumatriptan 0.2 spray

    • Formulation of: Sumatriptan
    • Dosage form: Spray
    • Active ingredient moieties: Sumatriptan
    Sumatriptan spray, for nasal administration, consisting of: 0.2mg/uL sumatriptan.
    6.00
    2 votes
    193

    Natural medicine 0.102/0.102 liquid

    • Formulation of: Arnica montana/Arnica montana root homeopathic preparation
    • Dosage form: Liquid
    • Active ingredient moieties: Arnica montana
    Natural medicine liquid, for oral administration, consisting of: 0.102[hp_X]/mL arnica montana ; 0.102[hp_X]/mL arnica montana root.Purpose: HPUS active ingredients                                Purpose Equal volumes of each ingredient in 6X, 30X, 6C, 30C, and LM1 potencies. Arnica montana.......................................traumatic injury, sprains, bruises, body aches, muscle pain, inflammation
    Arnica montana radix..............................redness and swelling, sensitivity to touch
    Reference image of arnica.jpg
    5.00
    3 votes
    194
    4.25
    4 votes
    195

    Collagenase santyl 250 ointment

    • Formulation of: Collagenase
    • Dosage form: Ointment
    • Active ingredient moieties: Collagenase
    Collagenase santyl ointment, for topical administration, consisting of: 250U/g collagenase (clostridium histolyticum gene colh isoenzyme aux-ii).
    5.50
    2 votes
    196

    Ketorolac tromethamine 15.75 metered spray

    • Formulation of: Ketorolac
    • Dosage form: Metered Spray
    • Active ingredient moieties: Ketorolac
    Ketorolac tromethamine metered spray, for nasal administration, consisting of: 15.75mg ketorolac tromethamine.Indications:SPRIX is indicated in adult patients for the short term (up to 5 days) management of moderate to moderately severe pain that requires analgesia at the opioid level. (1)
    5.50
    2 votes
    197

    Sodium monofluorophosphate 8.4 dentifrice gel

    • Formulation of: Fluoride
    • Dosage form: Dentifrice Gel
    • Active ingredient moieties: Fluoride
    Sodium monofluorophosphate dentifrice gel, for dental administration, consisting of: 8.4mg/g sodium monofluorophosphate.Purpose: Purpose
    Anticavity toothpolish
    5.50
    2 votes
    198

    Venlafaxine hydrochloride 150 extended release film coated tablet

    • Formulation of: Venlafaxine
    • Dosage form: Extended release film coated tablet
    • Active ingredient moieties: Venlafaxine
    Venlafaxine hydrochloride extended release film coated tablet, for oral administration, consisting of: 150mg/tablet venlafaxine hydrochloride.Indications:Venlafaxine Extended Release Tablets are a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for:
    • Major Depressive Disorder (MDD) (1.1)
    • Social Anxiety Disorder (SAD) (1.2)
    5.50
    2 votes
    199

    Codeine base 100 pellet

    • Formulation of: Codeine homeopathic preparation
    • Dosage form: Pellet
    • Active ingredient moieties: Codeine
    Codeine base pellet, for sublingual administration, consisting of: 100[hp_C]/pellet codeine.
    4.67
    3 votes
    200

    Finasteride 5 tablet

    • Formulation of: Finasteride
    • Dosage form: Tablet
    • Active ingredient moieties: Finasteride
    Finasteride tablet, for oral administration, consisting of: 5mg/tablet finasteride.Indications:
    Finasteride tablets USP, is a 5α-reductase inhibitor, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to (1.1):
    •Improve symptoms
    • Reduce the risk of the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy.

    Limitations of Use: Finasteride tablets USP is not approved for the prevention of prostate cancer (1.3).

    4.67
    3 votes
    201

    Alpha-1-proteinase inhibitor (human) 20 injectable solution

    • Formulation of: .alpha.1-proteinase inhibitor human
    • Dosage form: Injectable solution
    • Active ingredient moieties: .alpha.1-proteinase inhibitor human
    Alpha-1-proteinase inhibitor (human) injectable solution, for intravenous administration, consisting of: 20mg/mL .alpha.1-proteinase inhibitor human.Indications:GLASSIA is an alpha1-proteinase inhibitor that is indicated for chronic augmentation and maintenance therapy in adults with emphysema due to congenital deficiency of alpha1-proteinase inhibitor (Alpha1-PI), also known as alpha1-antitrypsin deficiency (1).
    • The effect of augmentation therapy with any alpha1-proteinase inhibitor on pulmonary exacerbations and on the progression of emphysema in Alpha1-PI deficiency has not been demonstrated in randomized, controlled clinical trials (1).
    • Clinical data demonstrating the long-term effects of chronic augmentation and maintenance therapy of individuals with GLASSIA are not available (1).
    • GLASSIA is not indicated as therapy for lung disease in patients in whom severe Alpha1-PI deficiency has not been established (1).
    6.00
    1 votes
    202
    6.00
    1 votes
    203

    Rivastigmine 0.192 extended release patch

    • Formulation of: Rivastigmine
    • Dosage form: Extended Release Patch
    • Active ingredient moieties: Rivastigmine
    Rivastigmine extended release patch, for transdermal administration, consisting of: 0.192mg/h rivastigmine.Indications:Exelon Patch contains rivastigmine, an acetylcholinesterase inhibitor indicated for the: - Treatment of mild to moderate dementia of the Alzheimer’s type (1.1) - Treatment of mild to moderate dementia associated with Parkinson’s disease (1.2)
    6.00
    1 votes
    204

    Stannous fluoride 4.3 gel

    • Formulation of: Tin(II) fluoride
    • Dosage form: Gel
    • Active ingredient moieties: Fluoride
    Stannous fluoride gel, for oral administration, consisting of: 4.3g/g stannous fluoride.Purpose:Anticavity
    6.00
    1 votes
    205

    Titanium dioxide 0.0411 lotion

    • Formulation of: Titanium dioxide
    • Dosage form: Lotion
    • Active ingredient moieties: Titanium dioxide
    Titanium dioxide lotion, for topical administration, consisting of: 0.0411mL/mL titanium dioxide.
    6.00
    1 votes
    206

    Titanium dioxide 0.1 cream

    • Formulation of: Zinc cation/Titanium
    • Dosage form: Cream
    • Active ingredient moieties: Titanium dioxide
    Titanium dioxide cream, for cutaneous administration, consisting of: 0.1mL/mL titanium dioxide ; 0.01mL/mL zinc oxide.Purpose:Purpose: This combination of cosmetic can be used as a sun protection cream and as a cosmetic to cover your blemishes, scar and to tone up your skin tone.
    6.00
    1 votes
    207

    Coast maple 0.1 injectable solution

    • Formulation of: Acer macrophyllum pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Acer macrophyllum pollen
    Coast maple injectable solution, for intradermal / subcutaneous administration, consisting of: 0.1g/mL acer macrophyllum pollen.
    5.00
    2 votes
    208

    Prilocaine and epinephrine 0.005/40 injectable solution

    • Formulation of: Prilocaine/Epinephrine
    • Dosage form: Injectable solution
    • Active ingredient moieties: Prilocaine
    Prilocaine and epinephrine injectable solution, for subcutaneous administration, consisting of: 0.005mg/mL epinephrine bitartrate ; 40mg/mL prilocaine hydrochloride.
    5.00
    2 votes
    209

    Calcium pantothenate, cupric sulfate anhydrous, cyanocobalamin, folic acid, iron, magnesium sulfate, manganese sulfate, niacinamide, pyridoxine hydrochloride, riboflavin, sodium ascorbate, thiamine mononitrate, and zinc sulfate 10/0.8/15/1/106/6.9/1.3/30/

    • Formulation of: Iron/Sodium cation/Thiamine/Riboflavin/Pyridoxine/Folic acid/Cyanocobalamin/Niacinamide/Pantothenic acid/Zinc/Magnesium/Manganese/Copper
    • Dosage form: Capsule
    • Active ingredient moieties: Iron
    Calcium pantothenate, cupric sulfate anhydrous, cyanocobalamin, folic acid, iron, magnesium sulfate, manganese sulfate, niacinamide, pyridoxine hydrochloride, riboflavin, sodium ascorbate, thiamine mononitrate, and zinc sulfate capsule, for oral administration, consisting of: 10mg/capsule calcium pantothenate ; 0.8mg/capsule cupric sulfate anhydrous ; 15ug/capsule cyanocobalamin ; 1mg/capsule folic acid ; 106mg/capsule iron ; 6.9mg/capsule magnesium sulfate ; 1.3mg/capsule manganese sulfate ; 30mg/capsule niacinamide ; 5mg/capsule pyridoxine hydrochloride ; 6mg/capsule riboflavin ; 200mg/capsule sodium ascorbate ; 10mg/capsule thiamine mononitrate ; 18.2mg/capsule zinc sulfate.
    4.50
    2 votes
    210

    Lime, citrus 50 injectable solution

    • Formulation of: Lime (citrus) extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Lime
    Lime, citrus injectable solution, for percutaneous / subcutaneous administration, consisting of: 50mg/mL lime (citrus).
    4.50
    2 votes
    211
    4.50
    2 votes
    212

    Quercus macrocarpa pollen 50 injectable solution

    • Formulation of: Quercus macrocarpa pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Quercus macrocarpa pollen
    Quercus macrocarpa pollen injectable solution, for percutaneous / subcutaneous administration, consisting of: 50mg/mL quercus macrocarpa pollen.
    4.50
    2 votes
    213

    Budesonide and formoterol fumarate dihydrate 160/4.5 aerosol

    • Formulation of: Budesonide/formoterol
    • Dosage form: Aerosol
    • Active ingredient moieties: Budesonide
    Budesonide and formoterol fumarate dihydrate aerosol, for respiratory (inhalation) administration, consisting of: 160ug budesonide ; 4.5ug formoterol fumarate dihydrate.Indications:SYMBICORT is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist indicated for: • Treatment of asthma in patients 12 years of age and older. (1.1) • Maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. (1.2) Important limitations: • Not indicated for the relief of acute bronchospasm. (1.1, 1.2)
    5.00
    1 votes
    214

    Conjugated estrogens and medroxyprogesterone acetate 0.625/2.5 sugar coated tablet

    • Formulation of: Estrogens, conjugated/Medroxyprogesterone
    • Dosage form: Sugar coated tablet
    • Active ingredient moieties: Estrogens, Conjugated
    Conjugated estrogens and medroxyprogesterone acetate sugar coated tablet, for oral administration, consisting of: 0.625mg/tablet estrogens, conjugated ; 2.5mg/tablet medroxyprogesterone acetate.Indications:PREMPRO/PREMPHASE is an estrogen/progestin indicated in women with intact uteri for:
    • Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause (1.1)
    • Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause (1.2)
    • Prevention of Postmenopausal Osteoporosis (1.3)
    5.00
    1 votes
    215

    Diphenhydramine citrate and ibuprofen 38/200 coated tablet

    • Formulation of: Diphenhydramine/Ibuprofen
    • Dosage form: Coated tablet
    • Active ingredient moieties: Diphenhydramine
    Diphenhydramine citrate and ibuprofen coated tablet, for oral administration, consisting of: 38mg/tablet diphenhydramine citrate ; 200mg/tablet ibuprofen.Purpose:Nighttime sleep-aid Pain reliever
    5.00
    1 votes
    216

    Pilocarpine hydrochloride 20 solution/drops

    • Formulation of: Pilocarpine
    • Dosage form: Solution/drops
    • Active ingredient moieties: Pilocarpine
    Pilocarpine hydrochloride solution/drops, for ophthalmic administration, consisting of: 20mg/mL pilocarpine hydrochloride.
    5.00
    1 votes
    217

    Rumex crispus pollen 10000 injectable solution

    • Formulation of: Rumex crispus top extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Rumex crispus top
    Rumex crispus pollen injectable solution, for intradermal / subcutaneous administration, consisting of: 10000[PNU]/mL rumex crispus pollen.
    5.00
    1 votes
    218

    Parsley 50 injectable solution

    • Formulation of: Parsley extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Parsley
    Parsley injectable solution, for percutaneous / subcutaneous administration, consisting of: 50mg/mL parsley.
    4.00
    2 votes
    219
    4.00
    1 votes
    220

    Aloe vera flower 0.18 cream

    • Formulation of: Aloe vera flower
    • Dosage form: Cream
    • Active ingredient moieties: Aloe vera flower
    Aloe vera flower cream, for topical administration, consisting of: 0.18mL/mL aloe vera flower.
    4.00
    1 votes
    221

    Alprazolam 0.25 orally disintegrating tablet

    • Formulation of: Alprazolam
    • Dosage form: Orally disintegrating tablet
    • Active ingredient moieties: Alprazolam
    Alprazolam orally disintegrating tablet, for oral administration, consisting of: 0.25mg/tablet alprazolam.Indications:NIRAVAM® is a benzodiazepine indicated for:
    • the treatment of generalized anxiety disorder (1.1), The efficacy of alprazolam was demonstrated in 5 short-term, placebo-controlled trials. (14)
    • the treatment of panic disorder, with or without agoraphobia (1.2). The efficacy of alprazolam in the treatment of panic disorder was established in 2 short-term, placebo-controlled trials. (14)
    4.00
    1 votes
    222

    Cefotaxime 10 injection

    • Formulation of: Cefotaxime
    • Dosage form: Injectable
    • Active ingredient moieties: Cefotaxime
    Cefotaxime injection, for intravenous administration, consisting of: 10g cefotaxime sodium.
    4.00
    1 votes
    223

    Dexmethylphenidate hydrochloride 35 extended release capsule

    • Formulation of: Dexmethylphenidate
    • Dosage form: Extended release capsule
    • Active ingredient moieties: Dexmethylphenidate
    Dexmethylphenidate hydrochloride extended release capsule, for oral administration, consisting of: 35mg/capsule dexmethylphenidate hydrochloride.Indications:Focalin XR is a CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older (1)
    4.00
    1 votes
    224

    Flu-cold 12/12/3/12/12/12/12/30/30 liquid

    • Formulation of: Echinacea angustifolia/Arsenic trioxide/Baptisia tinctoria root/Eupatorium perfoliatum flowering top/Gelsemium sempervirens root/Lycopodium clavatum spore/Phosphorus/Rancid beef/Toxicodendron pubescens leaf homeopathic preparation
    • Dosage form: Liquid
    • Active ingredient moieties: Echinacea angustifolia
    Flu-cold liquid, for oral administration, consisting of: 12[hp_X]/mL arsenic trioxide ; 12[hp_X]/mL baptisia tinctoria root ; 3[hp_X]/mL echinacea angustifolia ; 12[hp_X]/mL eupatorium perfoliatum flowering top ; 12kg/mL gelsemium sempervirens root ; 12[hp_X]/mL lycopodium clavatum spore ; 12[hp_X]/mL phosphorus ; 30[hp_X]/mL rancid beef ; 30[hp_X]/mL toxicodendron pubescens leaf.Purpose: Indications: For the temporary relief of cold and flu symptoms.
    4.00
    1 votes
    225
    4.00
    1 votes
    226

    Terbinafine hydrochloride 0.01 liquid

    • Formulation of: Terbinafine
    • Dosage form: Liquid
    • Active ingredient moieties: Terbinafine
    Terbinafine hydrochloride liquid, for topical administration, consisting of: 0.01mL/mL terbinafine hydrochloride.Purpose:Antifungal
    4.00
    1 votes
    227

    Topotecan hydrochloride 0.25 capsule

    • Formulation of: Topotecan
    • Dosage form: Capsule
    • Active ingredient moieties: Topotecan
    Topotecan hydrochloride capsule, for oral administration, consisting of: 0.25mg/capsule topotecan hydrochloride.Indications:HYCAMTIN is a topoisomerase inhibitor indicated for treatment of patients with relapsed small cell lung cancer. (1)
    4.00
    1 votes
    228

    Undecylenic acid 0.1 cream

    • Formulation of: Undecylenic acid
    • Dosage form: Cream
    • Active ingredient moieties: Undecylenic acid
    Undecylenic acid cream, for topical administration, consisting of: 0.1mg/mg undecylenic acid.Purpose:Cures Athlete's Foot (tinea pedis) jock itch (tinea cruris) and ringworm (tinea corporis).
    4.00
    1 votes
    229

    Acetaminophen, pamabrom 500/25 film coated tablet

    • Formulation of: Acetaminophen/Pamabrom
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Paracetamol
    Acetaminophen, pamabrom film coated tablet, for oral administration, consisting of: 500mg/tablet acetaminophen ; 25mg/tablet pamabrom.Purpose:Analgesic (pain reliever) Diuretic
    0.00
    0 votes
    230

    Actaea spicata root 30 pellet

    • Formulation of: Actaea spicata root homeopathic preparation
    • Dosage form: Pellet
    • Active ingredient moieties: Actaea spicata root
    Actaea spicata root pellet, for oral administration, consisting of: 30[hp_C]/mL actaea spicata root.Purpose:Purpose: Rheumatism
    0.00
    0 votes
    231

    Carbidopa and levodopa 25/250 tablet

    • Formulation of: Carbidopa/levodopa
    • Dosage form: Tablet
    • Active ingredient moieties: Carbidopa
    Carbidopa and levodopa tablet, for oral administration, consisting of: 25mg/tablet carbidopa ; 250mg/tablet levodopa.
    0.00
    0 votes
    232

    Carbon disulfide 30 pellet

    • Formulation of: Carbonate ion homeopathic preparation
    • Dosage form: Pellet
    • Active ingredient moieties: Carbonate
    Carbon disulfide pellet, for oral administration, consisting of: 30[hp_C]/mL carbon disulfide.Purpose:Purpose: HEADACHE RHEUMATISM
    0.00
    0 votes
    233

    Cyclosporine 100 gelatin coated capsule

    • Formulation of: Ciclosporin
    • Dosage form: Gelatin coated capsule
    • Active ingredient moieties: Ciclosporin
    Cyclosporine gelatin coated capsule, for oral administration, consisting of: 100mg/capsule cyclosporine.
    0.00
    0 votes
    234

    Disopyramide phosphate 150 capsule

    • Formulation of: Disopyramide
    • Dosage form: Capsule
    • Active ingredient moieties: Disopyramide
    Disopyramide phosphate capsule, for oral administration, consisting of: 150mg/capsule disopyramide phosphate.
    0.00
    0 votes
    235

    Elymus repens pollen 20000 injectable solution

    • Formulation of: Elymus repens pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Elymus repens pollen
    Elymus repens pollen injectable solution, for intradermal / subcutaneous administration, consisting of: 20000[PNU]/mL elymus repens pollen.
    0.00
    0 votes
    236

    Epoetin alfa 20000 solution

    • Formulation of: Erythropoietin
    • Dosage form: Solution
    • Active ingredient moieties: Erythropoietin
    Epoetin alfa solution, for intravenous / subcutaneous administration, consisting of: 20000[iU]/mL erythropoietin.Indications:Epogen is an erythropoiesis-stimulating agent (ESA) indicated for:
    • Treatment of anemia due to
      • Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis (1.1).
      • Zidovudine in HIV-infected patients (1.2).
      • The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy (1.3).
    • Reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, nonvascular surgery (1.4).

    Limitations of Use Epogen has not been shown to improve quality of life, fatigue, or patient well-being (1.5).
    Epogen is not indicated for use:
    • In patients with cancer receiving hormonal agents, biologic products, or radiotherapy, unless also receiving concomitant myelosuppressive chemotherapy (1.5).
    • In patients with cancer receiving myelosuppressive chemotherapy when the anticipated outcome is cure (1.5).
    • In patients scheduled for surgery who are willing to donate autologous blood (1.5).
    • In patients undergoing cardiac or vascular surgery (1.5).
    • As a substitute for RBC transfusions in patients who require immediate correction of anemia (1.5).
    0.00
    0 votes
    237

    Epstein barr virus remedy 100x 100 liquid

    • Formulation of: Human herpesvirus 4 homeopathic preparation
    • Dosage form: Liquid
    • Active ingredient moieties: Human herpesvirus 4
    Epstein barr virus remedy 100x liquid, for administration, consisting of: 100[hp_X]/mL human herpesvirus 4.
    0.00
    0 votes
    238

    Ginkgo leaf extract 0.05/0.01/0.5/0.008/0.05 liquid

    • Formulation of: Ginkgo/Asian ginseng/Creatine/Taurine/Ascorbic acid
    • Dosage form: Liquid
    • Active ingredient moieties: Ginkgo biloba
    Ginkgo leaf extract liquid, for oral administration, consisting of: 0.05mg/mg ascorbic acid ; 0.01mg/mg asian ginseng ; 0.5mg/mg creatine ; 0.008mg/mg ginkgo ; 0.05mg/mg taurine.
    0.00
    0 votes
    239

    Hydrochlorothiazide 25 tablet

    • Formulation of: Hydrochlorothiazide
    • Dosage form: Tablet
    • Active ingredient moieties: Hydrochlorothiazide
    Hydrochlorothiazide tablet, for oral administration, consisting of: 25mg/tablet hydrochlorothiazide.
    0.00
    0 votes
    240

    Ipratropium bromide monhydrate 18 metered aerosol

    • Formulation of: Ipratropium bromide
    • Dosage form: Metered aerosol
    • Active ingredient moieties: Ipratropium bromide
    Ipratropium bromide monhydrate metered aerosol, for respiratory (inhalation) administration, consisting of: 18ug/inhalation ipratropium bromide.
    0.00
    0 votes
    241

    Iris germanica var. florentina root 50 injectable solution

    • Formulation of: Iris germanica var. florentina root extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Iris germanica var. florentina root
    Iris germanica var. florentina root injectable solution, for percutaneous / subcutaneous administration, consisting of: 50mg/mL iris germanica var. florentina root.
    0.00
    0 votes
    242

    Levocetirizine dihydrochloride 5 film coated tablet

    • Formulation of: Levocetirizine
    • Dosage form: Film Coated Tablet
    • Active ingredient moieties: Levocetirizine
    Levocetirizine dihydrochloride film coated tablet, for oral administration, consisting of: 5mg/tablet levocetirizine dihydrochloride.Indications:Levocetirizine Dihydrochloride is a histamine H1-receptor antagonist indicated for:
    • The relief of symptoms associated with seasonal and perennial allergic rhinitis (1.1, 1.2)
    • The treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria (1.3)
    0.00
    0 votes
    243
    0.00
    0 votes
    244

    Octinoxate, oxybenzone 0.06/0.03 lipstick

    • Formulation of: Octinoxate/Oxybenzone
    • Dosage form: Lipstick
    • Active ingredient moieties: Octinoxate
    Octinoxate, oxybenzone lipstick, for topical administration, consisting of: 0.06mg/mg octinoxate ; 0.03mg/mg oxybenzone.
    0.00
    0 votes
    245

    Pancrelipase 56000/20000/44000 delayed release capsule

    • Formulation of: Pancrelipase
    • Dosage form: Delayed Release Capsule
    • Active ingredient moieties: Pancrelipase
    Pancrelipase delayed release capsule, for oral administration, consisting of: 56000[USP'U]/capsule pancrelipase amylase ; 20000[USP'U]/capsule pancrelipase lipase ; 44000[USP'U]/capsule pancrelipase protease.
    0.00
    0 votes
    246

    Penicillium glabrum 0.4 liquid

    • Formulation of: Penicillium glabrum homeopathic preparation
    • Dosage form: Liquid
    • Active ingredient moieties: Penicillium glabrum
    Penicillium glabrum liquid, for oral administration, consisting of: 0.4[hp_X]/mL penicillium glabrum.
    0.00
    0 votes
    247

    Pseudomonas aeruginosa 0.6 solution/drops

    • Formulation of: Pseudomonas aeruginosa homeopathic preparation
    • Dosage form: Solution/drops
    • Active ingredient moieties: Pseudomonas aeruginosa
    Pseudomonas aeruginosa solution/drops, for oral administration, consisting of: 0.6[hp_X]/mL pseudomonas aeruginosa.
    0.00
    0 votes
    248

    Scleranthus, 200 liquid

    • Formulation of: Scleranthus annuus flowering top homeopathic preparation
    • Dosage form: Liquid
    • Active ingredient moieties: Scleranthus annuus flowering top
    Scleranthus, liquid, for oral administration, consisting of: 200[hp_C]/mL scleranthus annuus flowering top.Purpose: INDICATIONS: For temporary relief of uncertainty, indecision, vacillation; fluctuating moods.
    0.00
    0 votes
    249

    Triclosan 3 lotion

    • Formulation of: Triclosan
    • Dosage form: Lotion
    • Active ingredient moieties: Undecylenic acid
    Triclosan lotion, for topical administration, consisting of: 3mg/g triclosan.Purpose:Antiseptic
    0.00
    0 votes
    250

    Washington/oregon coastal weed mixture 0.0071/0.0071/0.0071/0.0071/0.0071/0.0071/0.0071 injectable solution

    • Formulation of: Xanthium strumarium pollen/Artemisia vulgaris pollen/Plantago lanceolata pollen/Chenopodium album pollen/Amaranthus retroflexus pollen/Rumex acetosella pollen/Rumex crispus pollen extract
    • Dosage form: Injectable solution
    • Active ingredient moieties: Xanthium strumarium pollen
    Washington/oregon coastal weed mixture injectable solution, for subcutaneous / intradermal administration, consisting of: 0.0071g/mL amaranthus retroflexus pollen ; 0.0071g/mL artemisia vulgaris pollen ; 0.0071g/mL chenopodium album pollen ; 0.0071g/mL plantago lanceolata pollen ; 0.0071g/mL rumex acetosella pollen ; 0.0071g/mL rumex crispus pollen ; 0.0071g/mL xanthium strumarium pollen.
    0.00
    0 votes
    Get your friends to vote! Spread this URL or share:

    Discuss Best Drug formulation of All Time

    Top List Voters